SunOpta (STKL) 10-K 2 Mar 22 2022 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Millions	12 Months Ended
	Jan. 01, 2022	Feb. 25, 2022	Jul. 03, 2021
Entity Registrant Name	SUNOPTA INC.
Entity Shell Company	false
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	false
Entity Small Business	false
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Amendment Flag	false
Document Period End Date	Jan. 1, 2022
Document Type	10-K
Entity Common Stock, Shares Outstanding		107,391,671
Entity Public Float			$ 900
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	Yes
Entity Filer Category	Large Accelerated Filer
Current Fiscal Year End Date	--01-01
Entity Central Index Key	0000351834
Entity File Number	001-34198
Entity Address, Address Line One	7078 Shady Oak Road
Entity Address, City or Town	Eden Prairie
Entity Address, State or Province	MN
Entity Address, Postal Zip Code	55344
City Area Code	952
Local Phone Number	820-2518
Entity Interactive Data Current	Yes
Entity Tax Identification Number	00-0000000
Entity Incorporation, State or Country Code	Z4
Document Transition Report	false
Document Annual Report	true
ICFR Auditor Attestation Flag	true
Auditor Name	Ernst & Young LLP
Auditor Location	Minneapolis
Auditor Firm ID	42
The Nasdaq Stock Market | Common Shares
Trading Symbol	STKL
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Shares
The Toronto Stock Exchange | Common Shares
Trading Symbol	SOY
Title of 12(b) Security	Common Shares

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Statement [Abstract]
Revenues	$ 812,624	$ 789,213	$ 721,596
Cost of goods sold	714,539	680,136	656,093
Gross profit	98,085	109,077	65,503
Selling, general and administrative expenses	76,874	89,463	80,603
Intangible asset amortization	9,950	8,946	9,112
Other expense (income), net	8,890	23,393	(40,639)
Foreign exchange loss (gain)	1,112	(1,640)	(157)
Earnings (loss) from continuing operations before the following	1,259	(11,085)	16,584
Interest expense, net	8,769	30,042	32,765
Loss on retirement of debt	0	8,915	0
Loss from continuing operations before income taxes	(7,510)	(50,042)	(16,181)
Income tax benefit	(3,366)	(2,740)	(3,101)
Loss from continuing operations	(4,144)	(47,302)	(13,080)
Earnings from discontinued operations	0	124,820	12,322
Net earnings (loss)	(4,144)	77,518	(758)
Dividends and accretion on preferred stock	(4,197)	(10,328)	(8,022)
Earnings (loss) attributable to common shareholders	$ (8,341)	$ 67,190	$ (8,780)
Basic and diluted earnings (loss) per share
From continuing operations	$ (0.08)	$ (0.65)	$ (0.24)
From discontinued operations	0	1.40	0.14
Basic and diluted earnings (loss) per share	$ (0.08)	$ 0.75	$ (0.10)
Weighted-average common shares outstanding (000s)
Basic	104,098	89,234	87,787
Diluted	104,098	89,234	87,787

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Earnings (Loss) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Statement of Comprehensive Income [Abstract]
Loss from continuing operations	$ (4,144)	$ (47,302)	$ (13,080)
Earnings from discontinued operations	0	124,820	12,322
Net earnings (loss)	(4,144)	77,518	(758)
Other comprehensive earnings (loss)
Currency translation adjustment	0	2,405	(1,604)
Reclassification of accumulated currency translation adjustment of discontinued operations	0	10,229	0
Other comprehensive earnings (loss)	0	12,634	(1,604)
Comprehensive earnings (loss)	$ (4,144)	$ 90,152	$ (2,362)

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Current assets
Cash and cash equivalents	$ 227	$ 251
Accounts receivable, net of allowances for credit losses of $889 and $1,257, respectively	84,702	72,724
Inventories	220,143	147,748
Prepaid expenses and other current assets	16,638	21,665
Current income taxes recoverable	8,259	6,935
Total current assets	329,969	249,323
Property, plant and equipment, net	219,537	158,048
Operating lease right-of-use assets	47,245	35,172
Intangible assets, net	148,440	133,317
Goodwill	3,998	3,998
Other assets	5,930	5,757
Total assets	755,119	585,615
Current liabilities
Accounts payable and accrued liabilities	121,430	118,592
Income taxes payable	0	1,431
Current portion of long-term debt	9,760	3,478
Current portion of operating lease liabilities	12,203	12,750
Current portion of long-term liabilities	0	200
Total current liabilities	143,393	136,451
Long-term debt	214,843	66,245
Operating lease liabilities	39,028	24,582
Long-term liabilities	2,241	0
Deferred income taxes	22,485	25,408
Total liabilities	421,990	252,686
EQUITY
Common shares, no par value, unlimited shares authorized, 107,359,826 shares issued (January 2, 2021 - 90,194,220)	436,463	326,545
Additional paid-in capital	23,240	37,862
Accumulated deficit	(156,082)	(147,741)
Accumulated other comprehensive income	1,363	1,363
Total equity	304,984	218,029
Total equity and liabilities	755,119	585,615
Series A Preferred Stock [Member]
Current liabilities
Preferred Stock	0	87,305
Series B-1 Preferred Stock [Member]
Current liabilities
Preferred Stock	$ 28,145	$ 27,595

Consolidated Balance Sheet (Par

Consolidated Balance Sheet (Parentheticals) - USD ($) shares in Thousands, $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Statement of Financial Position [Abstract]
Allowances for credit losses	$ 889	$ 1,257
Common Stock, No Par Value	$ 0	$ 0
Common Stock Shares Issued	107,359,826	90,194,220

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Common shares [Member]	Additional paid-in capital [Member]	Accumulated deficit [Member]	Accumulated other comprehensive loss [Member]	Non-controlling interest [Member]	Total
Balance at Dec. 29, 2018	$ 314,357	$ 31,796	$ (206,151)	$ (9,667)	$ 1,504	$ 131,839
Balance (in shares) at Dec. 29, 2018	87,423
Employee share purchase plan	$ 475					475
Employee share purchase plan (in shares)	185
Stock incentive plan	$ 3,624	(3,120)				504
Stock incentive plan (in shares)	482
Withholding taxes on stock-based awards		(394)				(394)
Stock-based compensation		7,485				7,485
Dividends on preferred stock			(6,800)			(6,800)
Accretion on preferred stock			(1,222)			(1,222)
Loss from continuing operations			(13,080)			(13,080)
Earnings from discontinued operations			12,322		154	12,476
Currency translation adjustment				(1,604)	(10)	(1,614)
Capital contribution to majority-owned subsidiary					271	271
Dividend paid by subsidiary to non-controlling interest					(31)	(31)
Balance at Dec. 28, 2019	$ 318,456	35,767	(214,931)	(11,271)	1,888	129,909
Balance (in shares) at Dec. 28, 2019	88,090
Employee share purchase plan	$ 462					462
Employee share purchase plan (in shares)	114
Stock incentive plan	$ 7,627	(6,041)				1,586
Stock incentive plan (in shares)	1,990
Withholding taxes on stock-based awards		(4,080)				(4,080)
Stock-based compensation		12,216				12,216
Dividends on preferred stock			(8,636)			(8,636)
Accretion on preferred stock			(1,692)			(1,692)
Loss from continuing operations			(47,302)			(47,302)
Earnings from discontinued operations			124,820		(301)	124,519
Currency translation adjustment				2,405	(44)	2,361
Capital contribution to majority-owned subsidiary					67	67
Dividend paid by subsidiary to non-controlling interest					(66)	(66)
Disposition of discontinued operations				10,229	(1,544)	8,685
Balance at Jan. 02, 2021	$ 326,545	37,862	(147,741)	1,363	$ 0	218,029
Balance (in shares) at Jan. 02, 2021	90,194
Exchange of Series A preferred stock, net of share issuance costs of $287	$ 87,188					87,188
Exchange of Series A preferred stock, net of share issuance costs of $287 (in shares)	12,633
Employee share purchase plan	$ 583					583
Employee share purchase plan (in shares)	67
Stock incentive plan	$ 22,147	(15,004)				7,143
Stock incentive plan (in shares)	4,466
Withholding taxes on stock-based awards		(8,718)				(8,718)
Stock-based compensation		9,100				9,100
Dividends on preferred stock			(3,477)			(3,477)
Accretion on preferred stock			(720)			(720)
Loss from continuing operations			(4,144)			(4,144)
Balance at Jan. 01, 2022	$ 436,463	$ 23,240	$ (156,082)	$ 1,363		$ 304,984
Balance (in shares) at Jan. 01, 2022	107,360

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parentheticals) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Statement [Abstract]
Share issuance cost	$ 287	$ 0	$ 0

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Operating activities
Net earnings (loss)	$ (4,144)	$ 77,518	$ (758)
Earnings from discontinued operations	0	124,820	12,322
Loss from continuing operations	(4,144)	(47,302)	(13,080)
Items not affecting cash:
Depreciation and amortization	34,641	30,308	29,266
Amortization of debt issuance costs	1,353	4,078	2,721
Deferred income taxes	(2,923)	7,553	1,075
Stock-based compensation	9,100	11,676	6,340
Impairment of long-lived assets	3,206	7,803	0
Loss on foreign currency forward contract	0	12,658	0
Loss on retirement of debt	0	8,915	0
Gain on sale of business	0	0	(44,027)
Other	1,090	(157)	(34)
Changes in operating assets and liabilities, net of businesses sold	(63,755)	17,131	731
Net cash provided by (used in) operating activities of continuing operations	(21,432)	52,663	(17,008)
Net cash provided by operating activities of discontinued operations	0	39,033	26,817
Net cash provided by (used in) operating activities	(21,432)	91,696	9,809
Investing activities
Additions to property, plant and equipment	(58,297)	(24,754)	(28,387)
Additions to intangible assets	(25,073)	0	0
Proceeds from sale of assets	2,300	0	0
Cash settlement of foreign currency forward contract	0	(12,658)	0
Net proceeds from sale of businesses	0	0	63,324
Other	0	41	0
Net cash provided by (used in) investing activities of continuing operations	(81,070)	(37,371)	34,937
Net cash provided by (used in) investing activities of discontinued operations	(13,380)	361,889	(7,718)
Net cash provided by (used in) investing activities	(94,450)	324,518	27,219
Financing activities
Increase (decrease) under revolving credit facilities	106,016	(175,990)	(11,290)
Borrowings of long-term debt	32,800	5,179	637
Repayment of long-term debt, including premium paid	(13,671)	(231,431)	(1,281)
Payment of debt issuance costs	(2,561)	(4,888)	(412)
Proceeds from the exercise of stock options and employee share purchases	7,726	2,048	979
Payment of withholding taxes on stock-based awards	(8,718)	(4,080)	(394)
Payment of cash dividends on preferred stock	(5,247)	(4,078)	(6,800)
Payment of share issuance costs	(287)	0	0
Proceeds on issuance of preferred stock, net of issuance costs	0	26,804	0
Other	0	(185)	(19)
Net cash provided by (used in) financing activities of continuing operations	116,058	(386,621)	(18,580)
Net cash used in financing activities of discontinued operations	(200)	(31,063)	(20,183)
Net cash provided by (used in) financing activities	115,858	(417,684)	(38,763)
Decrease in cash and cash equivalents during the year	(24)	(1,470)	(1,735)
Cash and cash equivalents of discontinued operations:
Balance at the beginning of the year	0	1,370	2,501
Foreign exchange gain (loss) on cash and cash equivalents	0	223	(47)
Less: Balance at the end of year	0	0	(1,370)
Cash and cash equivalents, beginning of the year	251	128	779
Cash and cash equivalents, end of the year	$ 227	$ 251	$ 128

Significant Accounting Policies

Significant Accounting Policies	12 Months Ended
	Jan. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Significant Accounting Policies [Text Block]	1. Significant Accounting Policies Basis of Presentation These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned subsidiaries (collectively, the "Company" or "SunOpta") and have been prepared by the Company in United States ("U.S.") dollars and in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated on consolidation. Fiscal Year The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal year 2021 was a 52-week period ending on January 1, 2022, fiscal year 2020 was a 53-week period ending on January 2, 2021, and fiscal year 2019 was a 52-week period ending on December 28, 2019. Fiscal year 2022 will be a 52-week period ending on December 31, 2022, with quarterly periods ending on April 2, 2022, July 2, 2022, and October 1, 2022. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: allowances for credit losses; inventory reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; useful lives of property, plant and equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company's historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general business environment changes. Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on inputs categorized as follows: • Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. • Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. • Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability. When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. Foreign Currency Translation Exchange gains and losses on transactions occurring in a currency other than an operation's functional currency are recognized in earnings. Foreign currency gains and losses related to the remeasurement of the Company's Mexican operations into its U.S. dollar functional currency are recognized in earnings. Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less. The Company places its cash and cash equivalents with institutions of high creditworthiness. A ccounts Receivable Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is an estimate of the amount of probable losses in existing accounts receivable. The Company routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited. The Company closely monitors receivable balances and estimates an allowance for credit losses based on historical collection experience, and account aging analysis and trends, and evaluates the adequacy of the allowance each reporting period, considering individual customer account reviews, write-offs recorded in the period, sales forecasts and trends, and current and expected economic and customer-specific conditions. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered. As at January 1, 2022, three long-term customers represented approximately 14%, 13% and 12%, respectively, of the Company's consolidated trade receivables balance. The Company does not believe it is exposed to any significant credit risks with respect to these customers. Inventories Inventories are valued at the lower of cost and net realizable value. Shipping and handling costs are included in cost of goods sold on the consolidated statements of operations. Property, Plant and Equipment Property, plant and equipment assets are stated at cost, less accumulated depreciation. Cost includes capitalized interest on borrowings during the construction of major capital projects. Depreciation begins when an asset is ready for its intended use. Property, plant and equipment assets, other than land, are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years Leases At the lease commencement date, the Company recognizes a right-of-use lease asset for an amount equal to the lease liability, less any lease incentives. The lease liability is determined based on the present value of future lease payments over the lease term. The discount rate used to determine the present value of the future lease payments is the implicit rate in the lease if readily determinable. When that rate is not readily determinable, the Company applies its incremental borrowing rate, which its estimated using relevant interest rate yield curves and credit spreads derived from available market data and the Company's corporate credit rating. The Company excludes material non-lease components in determining the future lease payments. Material leases with an initial term of 12 months or less are recorded on the balance sheet. Intangible Assets The Company's finite-lived intangible assets primarily consist of customer relationships and brand names. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which are 10 to 25 years for customer relationships and 15 years for brand names. Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying amount of an asset is not recoverable, the fair value of the asset is determined typically using an income approach (discounted cash flow analysis). An impairment loss is recognized in earnings for any excess of the carrying amount of the asset over its fair value. Goodwill Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized but is instead tested for impairment at the reporting unit level at least annually, or whenever events or circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units using an income approach (discounted cash flow method). Goodwill impairment charges are recognized based on the excess of a reporting unit's carrying amount over its fair value. The results of the Company's annual impairment tests for goodwill are described in note 12. Derivative Instruments From time to time, the Company utilizes foreign currency forward contracts to manage its exposure to exchange rate fluctuations relating to foreign currency denominated inventory purchases and operating costs. Contracts are entered into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures. The Company does not enter into contracts for speculative purposes. Foreign currency forward contracts are recognized on the consolidated balance sheets at fair value. Gains or losses in the fair value of foreign currency forward contracts not specifically designated as hedging instruments are included in foreign exchange gain/loss on the consolidated statements of operations. For contracts designated as accounting hedges, gains or losses in fair value are recognized in other comprehensive earnings and subsequently recognized in earnings in the same period the hedged item affects earnings. The ineffective portion of an accounting hedge is recognized immediately in earnings. Debt Issuance Costs Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing arrangement using the effective interest method. Costs incurred to secure revolving credit facilities are recorded in other long-term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability. Income Taxes The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are recognized for deductible temporary differences and operating loss carryforwards, and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for the year plus or minus the change in deferred income tax assets and liabilities during the year. The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts income tax expense to reflect the Company's ongoing assessments of such matters, which requires judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax positions taken or expected to be taken in a tax return is a two-step process, whereby (i) the Company determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority. Stock Incentive Plan The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant. Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the number of awards that ultimately vest. Upon exercise, stock-based awards are settled through the issuance of common shares and are therefore treated as equity awards. Revenue Recognition Revenue is recognized when the Company transfers control of promised goods to its customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods. See note 2 for further discussion related to revenue recognition. Earnings Per Share Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding during the year. Earnings available to common shareholders is computed by deducting dividends and accretion on convertible preferred stock from earnings attributable to SunOpta Inc. The potential diluted effect of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average number of common shares used in the basic earnings per share calculation is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per share calculation. Contingencies In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses, tax-related matters, and claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum amount of the range is accrued as a liability. The Company recognizes an asset for insurance recoveries when a loss event has occurred and recovery is considered probable, to the extent that the potential recovery does not exceed the loss recognized. Recent Accounting Pronouncements In March 2020 and January 2021, the Financial Accounting Standards Board issued Accounting Standard Updates 2020-04 and 2021-01, Reference Rate Reform (Topic 848), that provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the transition away from LIBOR and other reference rates that are expected to be discontinued. The guidance in Topic 848 is effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company does not expect the guidance will have a material effect on its consolidated financial statements.

Revenue

Revenue	12 Months Ended
	Jan. 01, 2022
Revenue from Contract with Customer [Abstract]
Revenue [Text Block]	2. Revenue The Company procures, processes, and packages plant-based and fruit-based foods and beverages. The Company's customers include retailers, foodservice operators, branded food companies, and food manufacturers. Revenue is recognized when performance obligations under the terms of a contract with a customer are satisfied, which is upon the transfer of control of the contracted goods. Except for goods sold under bill-and-hold arrangements, control is transferred when title and physical possession of the product has transferred to the customer, which is at the point in time that product is shipped from the Company's facilities or delivered to a specified destination, depending on the terms of the contract, and the Company has a present right to payment. Under bill-and-hold arrangements, whereby the Company bills a customer for product to be delivered at a later date, control typically transfers when the product is ready for physical transfer to the customer, and the Company has a present right to payment. A performance obligation is a promise within a contract to transfer distinct goods to the customer. A contract with a customer may involve multiple products and/or multiple delivery dates, with the transfer of each product at each delivery date being considered a distinct performance obligation, as each of the Company's products has standalone utility to the customer. In these cases, the contract's transaction price is allocated to each performance obligation based on relative standalone selling prices and recognized as revenue when each individual product is transferred to the customer. Other promises in the contract-for example, the promise to provide quality assurance testing to ensure the product meets specification and is fit for its intended use-are not separable from the promise to deliver goods and are therefore not considered distinct. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods. Consideration is typically determined based on a fixed unit price for the quantity of product transferred. Certain contracts include rebates and other forms of variable consideration. For contracts involving variable consideration, the Company estimates the transaction price based on the amount of consideration to which it expects to be entitled. These estimates are determined based on historical experience and the expected outcome of the variable consideration, and are updated as new information becomes available, including actual claims paid, which indicate an estimate is not indicative of the expected results. Changes to these estimates are recorded in the period the adjustment is identified. The Company does not typically grant customers a general right of return for goods transferred but will generally accept returns of product for quality-related issues. The cost of satisfying this promise of quality is accounted for as an assurance-type warranty obligation rather than variable consideration. The Company's contracts do not typically include any significant payment terms, as payment is normally due shortly after the time of transfer. Revenue contracts are typically represented by short-term, binding purchase orders from customers, identifying the quantity and pricing for products to be transferred. Customer orders may be issued under long-term master supply arrangements. On their own, these master supply arrangements are typically not considered contracts for purposes of revenue recognition, as they do not create enforceable rights and obligations regarding the quantity, pricing, or timing of goods to be transferred (for example, by imposing minimum purchase obligations on the part of the customer). Certain master supply arrangements provide for the transfer of product on a bill-and-hold basis at the specific request of the customer. As goods are produced under these bill-and-hold arrangements to meet individual customer specifications, they are identifiable as belonging to the customer and cannot be directed to another customer. The timing of the Company's revenue recognition, customer billings and cash collections, does not result in significant unbilled receivables (contract assets) or customer advances (contract liabilities) on the consolidated balance sheet. Contract costs, such as sales commissions, are generally expensed as incurred given the short-term nature of the associated contracts. The following table presents a disaggregation of the Company's revenues based on categories used by the Company to evaluate sales performance: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Plant-Based Foods and Beverages Beverages and broths 376,525 332,390 286,381 Plant-based ingredients 31,135 28,156 22,944 Sunflower and roasted snacks 63,094 54,618 52,073 Total Plant-Based Foods and Beverages 470,754 415,164 361,398 Fruit-Based Foods and Beverages Frozen fruit and fruit-based ingredients (1) 279,128 325,102 306,060 Fruit snacks 62,742 48,947 43,792 Total Fruit-Based Foods and Beverages 341,870 374,049 349,852 Global Ingredients Soy and corn (2) - - 10,346 Total Global Ingredients - - 10,346 Total revenues 812,624 789,213 721,596 (1) In July 2021, the Company ceased the production and sale of fruit-based yogurt and bakery applications and transferred the production and sale of fruit-based toppings to its frozen fruit operations. Consequently, beginning in 2021, revenues generated from sales of fruit-based ingredients for the current and comparative periods have been included in the frozen fruit category, consistent with the realignment of the Company's internal reporting and evaluation of the overall sales performance of the Fruit-Based Foods and Beverages operating segment. (2) On February 22, 2019, the Company completed the sale of its soy and corn business (see note 5).

Acquisition of Dream and WestSo

Acquisition of Dream and WestSoy Brands	12 Months Ended
	Jan. 01, 2022
Business Combinations [Abstract]
Acquisition of Dream and WestSoy Brands [Text Block]	3. Acquisition of Dream ® and WestSoy ® Brands On April 15, 2021, the Company acquired the Dream and WestSoy plant-based beverage brands and related private label products in North America from The Hain Celestial Group, Inc. for a cash purchase price of $33 million, subject to a closing inventory adjustment. The final purchase price amounted to $31.7 million, including $0.4 million of direct transaction costs. The acquired assets included all inventories, trademarks, product formulations, and other intellectual property related to the Dream and WestSoy brands and did not include other working capital, property, plant and equipment, or employees. The transaction has been accounted for as an asset acquisition. The purchase price was allocated to the acquired inventories ($6.6 million) and brand name intangible assets ($25.1 million). The intangible assets are being amortized over their estimated useful life of approximately 15 years. Revenues and expenses related to the acquired Dream and WestSoy brands are included in the Company's consolidated financial statements from the acquisition date and are reported within the Plant-Based Foods and Beverages operating segment.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Jan. 01, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations [Text Block]	4. Discontinued Operations Tradin Organic On December 30, 2020 (the "Closing Date"), the Company completed the divestiture of its organic ingredient sourcing and production business, Tradin Organic, by selling all of the Company's interests and rights in The Organic Corporation B.V. and Tradin Organics USA LLC to Amsterdam Commodities N.V. ("Acomo"), pursuant to a Master Purchase Agreement, dated November 25, 2020, among the Company, Acomo, and the other parties thereto (the "Transaction"). The global operations of Tradin Organic included its organic and non-GMO ingredient sourcing operations centered in Amsterdam, The Netherlands, and Scott's Valley, California, together with its consumer-packaged premium juice co-manufacturing business, and its cocoa, sunflower, sesame, and avocado ingredient processing facilities located in the Netherlands, Bulgaria, and Ethiopia. Together with the Company's former soy and corn business (see note 5), Tradin Organic comprised the Company's former Global Ingredients operating segment. As of the Closing Date, the Company received cash consideration from the Transaction of $373.7 million (€305.1 million), net of cash acquired and debt assumed by Acomo. As described in note 23, Acomo has submitted a request for Summary Arbitral Proceedings regarding the allocation of the purchase price Acomo paid to acquire the shares of The Organic Corporation B.V. and the membership interests of Tradin Organics USA LLC in connection with the closing of the Transaction. The Company realized a cash loss of $12.7 million on a foreign currency forward contract to economically hedge the exchange rate risks on the euro-denominated cash consideration between the date of the Master Purchase Agreement and the Closing Date. The Company recorded this loss in other expense from continuing operations for the year ended January 2, 2021. In connection with the Transaction, on December 31, 2020, the Company repaid in full approximately $72 million of indebtedness attributable to Tradin Organic as of the Closing Date. In addition, on December 31, 2020, the Company utilized $233.3 million of the cash consideration from the Transaction to redeem all of its outstanding 9.5% senior secured second lien notes due October 2022 (including accrued interest and premium paid on redemption of $9.8 million in total) and repaid approximately $60 million of other outstanding indebtedness. As of the Closing Date, the Company recognized a pre-tax gain on sale of Tradin Organic of $111.8 million, which was recorded in discontinued operations. The following table reconciles the major components of the results of discontinued operations to the amounts reported in the consolidated statements of operations for the years ended January 2, 2021 and December 28, 2019: January 2, 2021 December 28, 2019 $ $ Revenues 503,036 468,426 Cost of goods sold 441,277 418,676 Selling, general and administrative expenses (1) 26,953 27,737 Intangible asset amortization 1,451 1,859 Other expense (income), net (782 ) 591 Foreign exchange loss (gain) 3,142 (1,147 ) Interest expense (2) 2,409 1,912 Earnings before gain of sale 28,586 18,798 Pre-tax gain on sale 111,818 - Earnings from discontinued operations before income taxes 140,404 18,798 Income tax expense 15,885 6,322 Earnings (loss) attributable to non-controlling interests (301 ) 154 Earnings from discontinued operations 124,820 12,322 (1) Selling, general and administrative expenses exclude management fees charged by SunOpta Corporate Services and include stock-based compensation expense attributed to employees of Tradin Organic. (2) Interest expense reflects interest on debt directly attributed to Tradin Organic.

Sale of Soy and Corn Business

Sale of Soy and Corn Business	12 Months Ended
	Jan. 01, 2022
Sale Of Soy And Corn Business [Abstract]
Sale of Soy and Corn Business [Text Block]	5. Sale of Soy and Corn Business On February 22, 2019, the Company's completed the sale of its specialty and organic soy and corn business to Pipeline Foods, LLC. The soy and corn business engaged in seed and grain conditioning and corn milling from five facilities located in the U.S. and formed part of the Company's former Global Ingredients segment. Net proceeds of $63.3 million from this transaction after costs of sale were initially used to repay outstanding indebtedness of the Company. As the soy and corn business did not qualify for presentation as discontinued operations, operating results for the business prior to February 22, 2019, were reported in continuing operations on the consolidated statements of operations for year ended December 28, 2019. For the period ended February 22, 2019, the soy and corn business generated revenues of $10.3 million and reported a loss before income taxes of $0.2 million. For the year ended December 28, 2019, the Company recognized a pre-tax gain on sale of the soy and corn business of $44.0 million, which was recorded in other income.

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Jan. 01, 2022
Derivative Assets (Liabilities), at Fair Value, Net, by Balance Sheet Classification [Abstract]
Derivative Financial Instruments [Text Block]	6. Derivative Financial Instruments As part of its risk management strategy, the Company from time to time enters into foreign currency forward contracts to reduce its exposure to fluctuations in foreign currency exchange rates. For any open contracts at period end, the contract rate is compared to the forward rate, and an unrealized gain or loss is recorded. These contracts are included in level 2 of the fair value hierarchy, as the inputs used in making the fair value determination are derived from and are corroborated by observable market data. As at January 1, 2022, the Company had no open foreign currency forward contracts. Prior to August 2021, the Company held a combination of foreign currency put and call option contracts (a zero-cost collar) to economically hedge its exposure to fluctuations in the Mexican peso related to purchases of fruit inventory and operating costs in Mexico. The Company did not designate these contracts as accounting hedges. The aggregate notional amount of these contracts was $11.8 million at inception and the contracts matured at various dates through July 2021. The collar had a ceiling rate of 24.00 Mexican pesos to the U.S. dollar and a floor rate of 21.14 Mexican pesos to the U.S. dollar. If the spot rate was between the ceiling and floor rates on the date of maturity of each of the contracts, then the Company did not recognize any gain or loss under these contracts. If the spot rate was below the floor rate of the collar, the Company recognized a foreign exchange gain, and if the spot rate was above the ceiling rate of the collar, the Company recognized a foreign exchange loss. For the years ended January 1, 2022 and January 2, 2021, the Company recognized a foreign exchange loss of $0.3 million and a foreign exchange gain of $2.2 million, respectively, on foreign currency forward contracts.

Accounts Receivable

Accounts Receivable	12 Months Ended
	Jan. 01, 2022
Receivables [Abstract]
Accounts Receivable [Text Block]	7. Accounts Receivable January 1, 2022 January 2, 2021 $ $ Trade receivables 85,591 73,981 Allowance for credit losses (889 ) (1,257 ) 84,702 72,724 The change in the allowance for credit losses for the years ended January 1, 2022 and January 2, 2021 is comprised as follows: January 1, 2022 January 2, 2021 $ $ Balance, beginning of year 1,257 630 Net addition (reduction) to provision (368 ) 627 Balance, end of year 889 1,257

Inventories

Inventories	12 Months Ended
	Jan. 01, 2022
Inventory Disclosure [Abstract]
Inventories [Text Block]	8. Inventories January 1, 2022 January 2, 2021 $ $ Raw materials and work-in-process 143,381 78,210 Finished goods 81,546 75,280 Inventory reserve (4,784 ) (5,742 ) 220,143 147,748 The change in the inventory reserve for the years ended January 1, 2022 and January 2, 2021 is comprised as follows: January 1, 2022 January 2, 2021 $ $ Balance, beginning of year 5,742 8,135 Additions to reserve during the year 5,854 3,081 Reserves applied and inventories written off during the year (6,812 ) (5,474 ) Balance, end of year 4,784 5,742

Property, Plant and Equipment

Property, Plant and Equipment	12 Months Ended
	Jan. 01, 2022
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Text Block]	9. Property, Plant and Equipment The major components of property, plant and equipment as at January 1, 2022 and January 2, 2021 were as follows: January 1, 2022 January 2, 2021 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Land 6,963 - 6,963 7,009 - 7,009 Buildings 94,935 22,510 72,425 75,308 23,587 51,721 Machinery and equipment 236,779 107,319 129,460 191,831 103,092 88,739 Enterprise software 19,900 11,740 8,160 25,250 16,009 9,241 Office furniture and equipment 5,429 3,130 2,299 7,258 6,157 1,101 Vehicles 1,445 1,215 230 1,850 1,613 237 365,451 145,914 219,537 308,506 150,458 158,048 As at January 1, 2022, property, plant and equipment included construction in process assets of $48.7 million (January 2, 2021 - $23.7 million) and $7.0 million (January 2, 2021 - $5.6 million) of spare parts inventory. Total depreciation expense included in cost of goods sold and selling, general and administrative expenses on the consolidated statements of operations related to property, plant and equipment for the year ended January 1, 2022 was $24.7 million (January 2, 2021 - $21.4 million; December 28, 2019 - $20.2 million).

Leases

Leases	12 Months Ended
	Jan. 01, 2022
Leases [Abstract]
Leases [Text Block]	10. Leases The Company leases certain manufacturing plants, warehouses, offices, and machinery and equipment. Prior to June 2021, the Company also leased certain farmland that was subleased to third-party growers. At the lease commencement date, the Company classifies a lease as a finance lease if it has the right to obtain substantially all of the economic benefits from the right-of-use assets, otherwise the lease is classified as an operating lease. The Company's leases have remaining noncancelable lease terms of less than one year to approximately 12 years, and typically require fixed monthly rental payments that may be adjusted annually to give effect to inflation. Real estate leases typically provide the Company options to extend the leases for up to 15 years. Machinery and equipment operating leases typically include purchase options for the fair market value of the underlying asset at the end of the lease term. Certain other leases for machinery and equipment include nominal purchase options at the end of the lease term that are reasonably certain of being exercised. The following tables present supplemental information related to leases: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Lease Costs Operating lease cost 13,806 16,647 18,192 Finance lease cost: Depreciation of right-of-use assets 5,922 2,647 1,439 Interest on lease liabilities 2,752 675 267 Sublease income (281 ) (504 ) (476 ) Net lease cost 22,199 19,465 19,422 January 1, 2022 January 2, 2021 $ $ Balance Sheet Classification Operating leases: Operating lease right-of-use assets 47,245 35,172 Current portion of operating lease liabilities 12,203 12,750 Operating lease liabilities 39,028 24,582 Total operating lease liabilities 51,231 37,332 Finance leases: Property, plant and equipment, gross 66,060 24,534 Accumulated depreciation (10,348 ) (5,787 ) Property, plant and equipment, net 55,712 18,747 Current portion of long-term debt 9,760 3,146 Long-term debt 43,034 15,667 Total finance lease liabilities 52,794 18,813 January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Cash Flow Information Cash paid (received) for amounts included in measurement of lease liabilities: Operating cash flows from operating leases 13,391 16,741 18,405 Operating cash flows from finance leases 2,752 675 267 Financing cash flows from finance leases (1) (4,828 ) 2,587 1,123 Right-of-use assets obtained in exchange for lease liabilities: Operating leases 29,015 5,962 2,760 Finance leases 29,906 5,179 14,549 Right-of-use assets and liabilities reduced through lease terminations or modifications: Operating leases (2,261 ) (23,667 ) - Finance leases (686 ) - - Impairment of operating lease right-of-use assets - (1,538 ) - (1) For the year ended January 1, 2022, net cash received for amounts included in financing cash flows from finance leases reflected cash advances of $13.6 million received by the Company under finance leases that have not commenced that relate to the construction of right-of-use assets controlled by the Company, partially offset by cash repayments of $8.8 million made by the Company related to finance leases that have commenced. January 1, 2022 January 2, 2021 December 28, 2019 Other Information Weighted-average remaining lease term (years): Operating leases 7.4 3.4 6.1 Finance leases 4.3 5.3 5.9 Weighted-average discount rate: Operating leases 5.0% 6.6% 9.2% Finance leases 6.6% 5.4% 4.5% Operating leases Finance leases $ $ Maturities of Lease Liabilities 2022 10,728 11,965 2023 10,184 14,035 2024 8,264 13,971 2025 6,245 14,665 2026 5,236 6,824 Thereafter 21,638 - Total lease payments 62,295 61,460 Less: imputed interest (11,064 ) (8,666 ) Total lease liabilities 51,231 52,794 See note 23 for a discussion of the Company's operating and finance lease commitments.

Intangible Assets

Intangible Assets	12 Months Ended
	Jan. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets [Text Block]	11. Intangible Assets The major components of intangible assets as at January 1, 2022 and January 2, 2021 were as follows: January 1, 2022 January 2, 2021 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Customer relationships 189,407 64,867 124,540 189,407 56,090 133,317 Brand names (see note 3) 25,073 1,173 23,900 - - - Other 1,919 1,919 - 1,919 1,919 - 216,399 67,959 148,440 191,326 58,009 133,317 Amortization expense associated with intangible assets in each of the next five fiscal years and thereafter is as follows: 2022 2023 2024 2025 2026 Thereafter Total $ $ $ $ $ $ $ Amortization expense 10,448 10,448 10,448 10,448 10,138 96,510 148,440

Goodwill

Goodwill	12 Months Ended
	Jan. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill [Text Block]	12. Goodwill As at January 1, 2022 and January 2, 2021, the Company had $4.0 million of goodwill recognized on the consolidated balance sheets, all of which was associated with the Fruit Snacks reporting unit of the Fruit-Based Foods and Beverages operating segment. For the years ended January 1, 2022, January 2, 2021 and December 28, 2019, the Company determined that goodwill was not impaired as the fair value of the Fruit Snacks reporting unit significantly exceeded its carrying amount. Prior to 2019, the Company recognized accumulated impairment losses of $213.8 million related to goodwill.

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	12 Months Ended
	Jan. 01, 2022
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities [Text Block]	13. Accounts Payable and Accrued Liabilities January 1, 2022 January 2, 2021 $ $ Accounts payable 105,386 73,204 Payroll and benefits 8,861 25,423 Accrued interest 846 41 Dividends payable on preferred stock (see note 15) 609 2,378 Accrued costs to sell related to Tradin Organic divestiture - 13,380 Accrued debt issuance costs - 1,690 Other accruals 5,728 2,476 121,430 118,592

Long-Term Debt

Long-Term Debt	12 Months Ended
	Jan. 01, 2022
Debt Disclosure [Abstract]
Long-Term Debt [Text Block]	14. Long-Term Debt January 1, 2022 January 2, 2021 $ $ Asset-based credit facilities: Revolving credit facilities 153,293 47,277 Term loan facility 11,606 — Total asset-based credit facilities 164,899 47,277 Finance lease liabilities (see note 10) 52,794 18,813 Other 6,910 3,633 Total debt 224,603 69,723 Less: current portion 9,760 3,478 Total long-term debt 214,843 66,245 Scheduled maturities of long-term debt, including finance lease liabilities, are as follows: $ 2022 11,965 2023 15,417 2024 15,629 2025 176,524 2026 10,711 Thereafter 3,023 Total gross maturities 233,269 Less: imputed interest (8,666 ) Total debt 224,603 Asset-Based Credit Facilities On December 31, 2020, the Company entered into a second amended and restated credit agreement (the "Credit Agreement"), among the Company, SunOpta Foods Inc. ("SunOpta Foods"), the other borrowers and guarantors party thereto, and the lenders party thereto (the "Lenders"). As part of the Credit Agreement, the Lenders provided a five-year, $250 million asset-based revolving credit facility, subject to borrowing base capacity (the "Tranche A Subfacility," and together with the Tranche B Subfacility defined below, the "Revolving Credit Facilities"), and a five-year $75 million delayed draw term loan facility which can be used for borrowings on or prior to June 30, 2022 (the "Term Loan Facility," and together with the Revolving Credit Facilities, the "Asset-Based Credit Facilities"), to finance certain capital expenditures. The Tranche A Subfacility includes borrowing capacity for letters of credit (see note 23) and provides for borrowings on same-day notice, including in the form of swingline loans. The Tranche A Subfacility and Term Loan Facility mature on December 31, 2025. On April 15, 2021, the Company entered into a first amendment to the Credit Agreement to allocate $20 million of the Lenders' commitments under the Tranche A Subfacility to a two-year, first-in-last-out tranche (the "Tranche B Subfacility"), which was drawn in full to finance a portion of the purchase price for the Dream and WestSoy brands (see note 3). The material terms governing the remaining $230 million of the Lenders' commitments under the Tranche A Subfacility remain unchanged. The Tranche B Subfacility is subject to a separate borrowing base applicable to certain eligible accounts receivable and inventory with advance rates separate from the Tranche A Subfacility. Borrowings repaid under the Tranche B Subfacility may not be borrowed again. Each repayment of Tranche B Subfacility loans will result in an increase of the Lenders' commitments under the Tranche A Subfacility, provided that such increases will not cause the aggregate Lenders' commitments under the Tranche A Subfacility to exceed $250 million. On July 2, 2021, the Company entered into a second amendment to the Credit Agreement to increase the customer concentration limit included in the borrowing base calculation under the Revolving Credit Faci lities. On February 25, 2022, the Company entered into a third amendment to the Credit Agreement to, among other things: (i) provide for the replacement of LIBOR with the Secured Overnight Financing Rate ("SOFR"); (ii) extend the maturity date of the Tranche B Subfacility by one year to April 15, 2024, with amortization payments on the aggregate principal amount of the Tranche B Subfacility of $2.5 million, payable at the end of each fiscal quarter, commencing with the fiscal quarter ending March 31, 2023, with the remaining amount payable at the maturity thereof; (iii) extend the period that the Term Loan Facility can be used for borrowings from June 30, 2022 to March 31, 2023; (iv) extend the repayment start date of the Term Loan Facility from July 31, 2022 to March 31, 2023, with monthly repayments equal to 1/84th of the then-outstanding principal amount of the Term Loan Facility; (v) amend the maximum senior funded leverage ratio with respect to the Term Loan Facility to 5.50 to 1.00 from the fiscal quarter ending March 31, 2022 to the fiscal quarter ending September 30, 2022, 5.00 to 1.00 for the fiscal quarter ending December 31, 2022, 4.75 to 1.00 from the fiscal quarter ending March 31, 2023 to the fiscal quarter ending June 30, 2023, 4.25 to 1.00 from the fiscal quarter ending September 30, 2023 to the fiscal quarter ending December 31, 2023, 3.50 to 1.00 from the fiscal quarter ending March 31, 2024 to the fiscal quarter ending June 30, 2024, and 3.25 to 1.00 from the fiscal quarter ending September 30, 2024 until the Term Loan Facility termination date; (vi) increase certain advance rates and add new classes of eligible assets to the Tranche A Subfacility borrowing base calculation; and (vii) delay by one year to January 1, 2023, a 0.25% margin reduction when the Company's total leverage ratio is less than a specific threshold. All obligations under the Asset-Based Credit Facilities are guaranteed by substantially all of the Company's direct and indirect wholly-owned material restricted subsidiaries organized in the U.S. and Canada (the "Guarantors") and, subject to certain exceptions, such obligations are secured by first priority liens on substantially all assets of the Company and the other borrowers and Guarantors. For the year ended January 1, 2022, the weighted-average interest rate on all outstanding borrowings under the Revolving Credit Facilities was 2.36%. Borrowings under the Asset-Based Credit Facilities bear interest based on various reference rates plus an applicable margin, which are set quarterly based on average borrowing availability for the preceding fiscal quarter. Effective from the date of the third amendment to the Credit Agreement, the applicable margin for loans under the Tranche A Subfacility range from 0.50% to 1.00% for base rate loans and from 1.50% to 2.00% for SOFR loans, bankers' acceptance equivalent loans and European base rate loans. The applicable margin on loans under the Tranche B Subfacility are the applicable margin for the Tranche A Subfacility plus 1.00%. With respect to loans under the Term Loan Facility, the applicable margin ranges from 1.25% to 1.75% for base rate loans and from 2.25% to 2.75% for SOFR loans. In addition, a credit spread adjustment of 0.10% applies to all SOFR loans. In addition to paying interest on outstanding principal under the Asset-Based Credit Facilities, the Company is required to pay commitment fees quarterly, in arrears, equal to (i) 0.25% of the average daily undrawn portion of the Revolving Credit Facilities and (ii) 0.375% of the undrawn portion of the Term Loan Facility. The Asset-Based Credit Facilities are subject to a number of covenants that, among other things, restrict the Company's ability to create liens on assets; sell assets and enter in sale and leaseback transactions; pay dividends, prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness, including finance lease obligations in excess of $150 million, and make guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations. In addition, the Company and its restricted subsidiaries are required to maintain a minimum fixed charge coverage ratio of 1.0 to 1.0 if excess availability is less than the greater of (i) $15.0 million or (ii) 10% of the lesser of (x) the aggregate commitments under the Revolving Credit Facilities and (y) the aggregate borrowing base, as well as the maximum senior funded leverage ratio covenant (as amended above) with respect to the Term Loan Facility. As at January 1, 2022, the Company was in compliance with all covenants of the Credit Agreement. Interest Expense, Net The components of interest expense, net are as follows: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Interest expense 7,685 26,816 30,950 Amortization of debt issuance costs 1,353 4,078 2,721 Interest income (269 ) (852 ) (906 ) Interest expense, net 8,769 30,042 32,765 Loss on Retirement of Debt For the year ended January 2, 2021, the Company recorded a loss of $8.9 million on the redemption and retirement in full of the $223.5 million principal amount of outstanding 9.5% senior secured second lien notes due October 2022 issued by SunOpta Foods. The second lien notes were redeemed at a redemption price equal to 102.375% of the principal amount of the notes, together with accrued and unpaid interest on the notes to the date of redemption.

Preferred Stock

Preferred Stock	12 Months Ended
	Jan. 01, 2022
Temporary Equity [Abstract]
Preferred Stock [Text Block]	15. Preferred Stock Series A Preferred Stock On October 7, 2016, the Company and SunOpta Foods entered into a subscription agreement (the "Series A Subscription Agreement") with Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P. (collectively, "Oaktree"). Pursuant to the Series A Subscription Agreement, SunOpta Foods issued an aggregate of 85,000 shares of Series A Preferred Stock (the "Series A Preferred Stock") to Oaktree for consideration in the amount of $85.0 million. In connection with the issuance of the Series A Preferred Stock, the Company incurred direct and incremental expenses of $6.0 million, which reduced the carrying value of the Series A Preferred Stock. The carrying value of the Series A Preferred Stock was being accreted through charges to accumulated deficit over the period preceding October 7, 2021, the date on or after which SunOpta Foods may have redeemed all the Series A Preferred Stock. On February 22, 2021 (the "Exchange Date"), Oaktree exchanged all of their shares of Series A Preferred Stock for 12,633,427 shares of common stock of the Company As at the Exchange Date, the carrying amount of the Series A Preferred Stock was $87.5 million, comprised of the initial liquidation preference of $85.0 million in the aggregate, together with $3.4 million of dividends paid in kind for the first and second quarters of 2020, less remaining unamortized issuance costs of $0.9 million. As at the Exchange Date, the Company derecognized the carrying amount of the Series A Preferred Stock and recognized a corresponding amount for the Common Shares issued on exchange, net of share issuance costs of $0.3 million. In connection with the exchange of the Series A Preferred Stock, all 12,633,427 Special Shares, Series 1 previously issued to Oaktree were redeemed by the Company. The Special Shares, Series 1 entitled Oaktree to one vote per Special Share, Series 1 on all matters submitted to a vote of the holders of Common Shares. Series B-1 Preferred Stock On April 15, 2020, the Company and SunOpta Foods entered into a subscription agreement (the "Series B Subscription Agreement") with Oaktree and Engaged Capital, LLC, Engaged Capital Flagship Master Fund, LP and Engaged Capital Co-Invest IV-A, LP (collectively, "Engaged"). On April 24, 2020, pursuant to the Series B Subscription Agreement, SunOpta Foods issued 15,000 shares of Series B-1 Preferred Stock to each of Oaktree and Engaged for aggregate consideration of $30.0 million and 30,000 shares total (the "Series B-1 Preferred Stock"). In connection with the issuance of the Series B-1 Preferred Stock, the Company incurred direct and incremental expenses of $3.2 million, which reduced the carrying value of the Series B-1 Preferred Stock. The carrying value of the Series B-1 Preferred Stock is being accreted through charges to accumulated deficit over the period preceding April 24, 2025. For the year ended January 1, 2022, these accretion charges amounted to $0.5 million (January 2, 2021 - $0.3 million). The Series B-1 Preferred Stock had an initial stated value and liquidation preference of $1,000 per share, which is adjusted for any non-cash dividends declared on the Series B-1 Preferred Stock (the "Series B-1 Liquidation Preference"). Cumulative preferred dividends accrue daily on the Series B-1 Preferred Stock at an annualized rate of 8.0% of the Series B-1 Liquidation Preference prior to September 30, 2029, and 10.0% of the liquidation preference thereafter (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the occurrence of certain events of non-compliance). Prior to September 30, 2029, SunOpta Foods may pay dividends in cash or elect, in lieu of paying cash, to add the amount that would have been paid to the Series B-1 Liquidation Preference. The failure to pay dividends in cash for any quarter ending after September 30, 2029 will be an event of non-compliance. For the second quarter of 2020, SunOpta Foods elected to declare dividends on the Series B-1 Preferred Stock to be paid in kind and, as a result, the aggregate Series B-1 Liquidation Preference increased by $0.4 million to $30.4 million, or approximately $1,015 per share. Since the second quarter of 2020, SunOpta Foods has elected to pay the quarterly dividend amount of $0.6 million in cash. As at January 1, 2022, the Company accrued unpaid dividends of $0.6 million for the fourth quarter of 2021, which are recorded in accounts payable and accrued liabilities on the consolidated balance sheet. At any time, the Series B-1 Preferred Stock may be exchanged, in whole or in part, into the number of Common Shares equal to, per share of Series B-1 Preferred Stock, the quotient of the Series B Liquidation Preference divided by $2.50 (such price, the "Series B-1 Exchange Price" and such quotient, the "Series B-1 Exchange Rate"). As at January 1, 2022, the aggregate shares of Series B-1 Preferred Stock outstanding were exchangeable into 12,178,667 Common Shares. The Series B-1 Exchange Price is subject to certain anti-dilution adjustments, including a weighted-average adjustment for issuances of Common Shares below the Series B-1 Exchange Price, provided that the Series B-1 Exchange Price may not be lower than $2.00 (subject to adjustment in certain circumstances). SunOpta Foods may cause the holders of the Series B-1 Preferred Stock to exchange all of their shares of Series B-1 Preferred Stock into a number of Common Shares equal to the number of shares of Series B-1 Preferred Stock outstanding multiplied by the Series B-1 Exchange Rate if (i) fewer than 10% of the shares of Series B-1 Preferred Stock issued on April 24, 2020 remain outstanding, or (ii) on or after April 24, 2023, the average volume-weighted average price of the Common Shares during the then preceding 20 trading day period is greater than 200% of the Series B-1 Exchange Price then in effect. At any time, if a holder of Series B-1 Preferred Stock elects to exchange, or SunOpta Foods causes an exchange of Series B Preferred Stock, the number of Common Shares delivered to each applicable holder may not cause such holder's beneficial ownership to exceed 19.99% of the Common Shares that would be outstanding immediately following such exchange (the "Series B-1 Exchange Cap"). At any time on or after April 24, 2025, SunOpta Foods may redeem all of the Series B-1 Preferred Stock for an amount per share equal to the value of the Series B-1 Liquidation Preference at such time, plus accrued and unpaid dividends. Oaktree and Engaged are entitled to vote the Series B-1 Preferred Stock with the Common Shares on an as-exchanged basis, subject to a permanent 19.99% voting cap. As a result of the voting cap, each of Oaktree and Engaged will only be able to vote its Series B-1 Preferred Stock to the extent that, when taken together with any other voting securities each investor controls, such votes do not exceed 19.99% of the votes eligible to be cast by all security holders of the Company. On April 24, 2020, the Company designated Special Shares, Series 2 to serve as the mechanism for attaching exchanged voting rights to the Series B-1 Preferred Stock. The Special Shares, Series 2 entitle the holder thereof to one vote per Special Share, Series 2 on all matters submitted to a vote of the holders of Common Shares, voting together as a single class, subject to certain exceptions. The Special Shares, Series 2 are not transferrable and the voting rights associated with the Special Shares, Series 2 will terminate upon the transfer of the shares of Series B-1 Preferred Stock to a third party, other than an affiliate of Oaktree or Engaged, as applicable.

Common Shares

Common Shares	12 Months Ended
	Jan. 01, 2022
Equity [Abstract]
Common Shares [Text Block]	16. Common Shares The Company is authorized to issue an unlimited number of Common Shares without par value and an unlimited number of special shares without par value.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Jan. 01, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation [Text Block]	17. Stock-Based Compensation For January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Selling, general and administrative expenses 9,100 12,570 10,471 Other income (1) — (894 ) (4,131 ) Earnings from discontinued operations (2) — 540 1,145 Total stock-based compensation expense 9,100 12,216 7,485 (1) Represents the reversal of previously recognized stock-based compensation related to forfeited awards previously granted to employees who were terminated in connection with restructuring activities undertaken by the Company. (2) Represents stock-based compensation attributed to employees of Tradin Organic. Stock Incentive Plan On May 28, 2013, the Company's shareholders approved the 2013 Stock Incentive Plan, as amended (the "2013 Plan"), which permits the grant of a variety of stock-based awards, including stock options, restricted stock units ("RSUs") and performance share units ("PSUs") to selected employees and directors of the Company. As at January 1, 2022, 4,373,448 securities remained available for issuance under the 2013 Plan. Stock Options Stock options granted to employees during the three-year period ended January 1, 2022 vest ratably on each of the first through third anniversaries of the grant date and expire on the tenth anniversary of the grant date. Stock options granted by the Company contain an exercise price that is equal to the closing market price of the shares on the day prior to the grant date. Any consideration paid by employees or directors on the exercise of stock options or purchase of stock is credited to capital stock. The following table summarizes stock option activity for the year ended January 1, 2022: Weighted- average Weighted- remaining average contractual Aggregate Stock options exercise price term (years) intrinsic value Outstanding, beginning of year 2,170,780 $ 6.95 Granted 142,499 14.77 Exercised (920,526 ) 7.18 Forfeited (333,375 ) 7.56 Outstanding, end of year 1,059,378 $ 7.75 6.5 $ 1,219 Exercisable, end of year 665,988 $ 7.46 5.2 $ 653 The total intrinsic value of stock options exercised during the year ended January 1, 2022 was $5.1 million. The following table summarizes non-vested stock option activity during the year ended January 1, 2022: Weighted- average grant- Stock options date fair value Non-vested, beginning of year 554,987 $ 2.54 Granted 142,499 8.10 Vested (208,477 ) 2.49 Forfeited (95,619 ) 3.26 Non-vested, end of year 393,390 $ 4.49 The weighted-average grant-date fair values of all stock options granted in the years ended January 1, 2022, January 2, 2021 and December 28, 2019, were $8.10, $2.52 and $1.70, respectively. The weighted-average assumptions used in the Black-Scholes option pricing model to determine the fair value of the stock options granted in those years were as follows: January 1, 2022 January 2, 2021 December 28, 2019 Grant-date stock price $14.77 $4.64 $3.57 Dividend yield (a) 0% 0% 0% Expected volatility (b) 61.7% 60.0% 48.6% Risk-free interest rate (c) 1.0% 0.4% 2.3% Expected life of options (years) (d) 6.0 6.0 5.8 (a) Determined based on expected annual dividend yield at the time of grant. (b) Determined based on historical volatility of the Company’s Common Shares over the expected life of the option. (c) Determined based on the yield on U.S. Treasury zero-coupon issues with maturity dates equal to the expected life of the option. (d) Determined based on the mid-point of vesting (one through three years) and expiration (10 years). Total compensation costs related to non-vested stock option awards not yet recognized as an expense was $1.3 million as at January 1, 2022, which will be amortized over a weighted-average remaining vesting period of 2.0 years. The following table summarizes stock options outstanding and exercisable as at January 1, 2022: Weighted- average remaining Weighted- Weighted- Exercise price range Outstanding contractual life average exercise Exercisable average exercise Low High options (years) price options price $ 3.25 $ 4.72 97,860 6.5 $ 3.58 87,060 $ 3.44 4.73 5.00 361,385 8.5 4.73 117,917 4.73 5.01 9.48 146,978 3.1 6.70 144,978 6.71 9.49 9.79 218,470 5.4 9.50 218,470 9.50 9.80 14.77 234,685 6.6 13.17 97,563 10.93 1,059,378 6.5 $ 7.75 665,988 $ 7.46 Restricted Stock Units RSUs granted to employees vest ratably on each of the first through third anniversaries of the grant date. RSUs granted to directors vest 100% The weighted-average grant-date fair values of all RSUs granted in the years ended January 1, 2022, January 2, 2021 and December 28, 2019, were $13.32, $3.20 and $3.33, respectively, based on the closing price of the Common Shares on the grant dates. The following table summarizes non-vested RSU activity during the year ended January 1, 2022: Weighted- average grant- RSUs date fair value Non-vested, beginning of year 647,299 $ 3.39 Granted 245,848 13.32 Vested (285,554 ) 3.93 Forfeited (101,582 ) 3.78 Non-vested, end of year 506,011 $ 7.71 The total intrinsic value of RSUs that vested during the year ended January 1, 2022 was $3.8 million. Total compensation costs related to non-vested RSU awards not yet recognized as an expense was $2.6 million as at January 1, 2022, which will be amortized over a weighted-average remaining vesting period of 2.0 years. Performance Share Units PSUs granted to certain employees under the Company's 2021, 2020 and 2019 short-term incentive plans and 2020 long-term incentive plan vest subject to the Company achieving predetermined measures of adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA") (the "EBITDA PSUs"). Each vested EBITDA PSU entitles the employee to receive one Common Share without payment of additional consideration. The weighted-average grant-date fair values of the EBITDA PSUs granted during the years ended January 1, 2022, January 2, 2021 and December 28, 2019, were $13.90, $3.54 and $3.42, respectively, based on the closing price of the Common Shares on the grant dates. The following table summarizes non-vested EBITDA PSU activity during the year ended January 1, 2022: Weighted- average grant- EBITDA PSUs date fair value Non-vested, beginning of year 3,004,675 $ 3.56 Granted 666,332 13.90 Vested (2,813,175 ) 3.53 Forfeited (187,661 ) 11.40 Non-vested, end of year 670,171 $ 11.77 The total intrinsic value of EBITDA PSUs that vested during the year ended January 1, 2022 under the Company's 2020 short-term and long-term incentive plans was $37.3 million. Each reporting period, the number of unvested EBITDA PSUs that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of EBITDA PSUs is amortized on a straight-line basis over the remaining requisite service period less amounts previously recognized. As at January 1, 2022, the compensation cost not yet recognized as an expense related to unvested EBITDA PSUs granted under the Company's 2020 long-term incentive plan that are currently expected to vest was $0.4 million, which will be amortized over a weighted-average remaining vesting period of 1.5 years. As the EBITDA performance condition under the Company's 2021 short-term incentive plan was not achieved, the Company did not recognize any compensation expense related to those EBITDA PSUs, which was estimated to be $9.0 million as of the grant date. The vesting of 74,428 PSUs granted to selected employees under the Company's 2021 long-term incentive plan is dependent on the Company's total shareholder return ("TSR") performance relative to food and beverage companies in a designated index during the three-year period commencing January 1, 2021 and continuing through December 31, 2023, and the employee's continued employment with the Company through April 15, 2024 (the "TSR PSUs"). The TSR for the Company and each of the companies in the designated index will be calculated using a 20-trading day average closing price as of December 31, 2023. The percentage of vested TSR PSUs may range from 0% to 200% based on the Company's achievement of predetermined TSR thresholds. Each vested TSR PSU entitles the employee to receive one Common Share without payment of additional consideration. A grant-date fair value of $23.40 was estimated for the TSR PSUs using a Monte Carlo valuation model with the following assumptions: Grant-date stock price $ 14.77 Dividend yield 0% Expected volatility (a) 76.9% Risk-free interest rate (b) 0.3% Expected life (in years) (c) 2.7 (a) Determined based on the historical volatility of the Common Shares over the performance period of the PSUs. (b) Determined based on U.S. Treasury yields with a remaining term equal to the performance period of the PSUs. (c) Determined based on the performance period of the PSUs. The following table summarized non-vested TSR PSU activity during the year ended January 1, 2022: Weighted- average grant- TSR PSUs date fair value Non-vested, beginning of year - $ - Granted 74,428 23.40 Vested - - Forfeited (3,082 ) 23.40 Non-vested, end of year 71,346 $ 23.40 Total compensation costs related to non-vested TSR PSU awards not yet recognized as an expense was $1.3 million as at January 1, 2022, which will be amortized over a remaining vesting period of 2.3 years. Chief Executive Officer On April 1, 2019, Joseph D. Ennen was appointed CEO of the Company. In connection with his appointment, the Company granted Mr. Ennen options to purchase 960,061 Common Shares, 512,619 RSUs (of which 215,000 were issued to equal the number of Common Shares purchased by Mr. Ennen on the open market within the 60-day period after his employment began) and 1,785,714 PSUs. The stock options vest on April 1, 2022, subject to Mr. Ennen's continued employment during the vesting period, and expire on April 1, 2029. Each vested stock option entitles Mr. Ennen to purchase one Common Share at an exercise price of $3.36, which was equal to the closing price of the Common Shares on April 1, 2019. The RSUs vest in three equal annual installments beginning on April 1, 2020, and each vested RSU entitles Mr. Ennen to receive one Common Share of the Company without payment of additional consideration. The vesting of 892,857 of the PSUs granted is subject to the Company achieving predetermined annual thresholds of adjusted EBITDA from continuing operations during fiscal years 2019 through 2022, as follows: 297,619 PSUs vest upon the Company achieving annual adjusted EBITDA of $43 million, another 297,619 vest upon the Company achieving annual adjusted EBITDA of $65 million, and the final 297,619 vest upon the Company achieving annual adjusted EBITDA of $87 million, and subject to Mr. Ennen's continued employment with the Company through the end of the fiscal year during which the adjusted EBITDA performance condition is achieved. The vesting of the other 892,857 PSUs that were granted is subject to the Common Shares achieving certain volume-weighted average trading prices during a performance period commencing on April 1, 2019 and ending on December 31, 2022, as follows: 297,619 PSUs vest upon achieving a trading price of $5.00 per share, another 297,619 vest upon achieving a trading price of $9.00 per share, and the final 297,619 vest upon achieving a trading price of $14.00 per share, in each case for 20 consecutive trading days, and subject to Mr. Ennen's continued employment with the Company through the date the stock price performance condition is achieved. Each vested PSU entitles Mr. Ennen to receive one Common Share without payment of additional consideration. The weighted-average grant-date fair values of the RSUs and PSUs subject to the adjusted EBITDA performance condition were estimated to be $3.46 and $3.36, respectively, based on the closing price of Common Shares on the dates of grant. A grant-date fair value of $1.68 was estimated for the stock options using the Black-Scholes option pricing model, and a weighted-average grant-date fair value of $1.77 was estimated for the PSUs subject to the stock price performance condition using a Monte Carlo valuation model. The following table summarizes the inputs to the Black-Scholes option-pricing and Monte Carlo valuation models: Stock Options PSUs Grant-date stock price $ 3.36 $ 3.36 Exercise price $ 3.36 NA Dividend yield 0% 0% Expected volatility (a) 47.9% 55.7% Risk-free interest rate (b) 2.4% 2.3% Expected life (in years) (c) 6.5 1.8 (a) Determined based on the historical volatility of the Common Shares over the expected life of the stock options and performance period of the PSUs. (b) Determined based on U.S. Treasury yields with a remaining term equal to the expected life of the stock options and performance period of the PSUs. (c) Determined based on the mid-point of vesting (three years) and expiration (ten years) for the stock options and the derived service period for the PSUs The aggregate grant-date fair value of the stock options, RSUs and PSUs awarded to Mr. Ennen was determined to be $8.0 million, which is being recognized on a straight-line basis over the vesting period for the stock options and RSUs and the derived service period for the PSUs. Each reporting period, the number of PSUs subject to the adjusted EBITDA performance condition that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of those PSUs is amortized over the remaining service period less amounts previously recognized. Total compensation costs related to Mr. Ennen's non-vested equity awards not yet recognized as an expense was $1.1 million as at January 1, 2022, which will be amortized over a weighted-average remaining vesting period of 0.8 years. The following table summarizes activity related to Mr. Ennen's non-vested equity awards during the year ended January 1, 2022: Stock EBITDA Stock price options RSUs PSUs PSUs Non-vested, beginning of year 960,061 341,746 892,857 297,619 Vested - (170,873 ) (297,619 ) (297,619 ) Non-vested, end of year 960,061 170,873 595,238 - The total intrinsic value of Mr. Ennen's equity awards that vested during the year ended January 1, 2022 was $11.5 million. Chief Financial Officer On September 3, 2019, Scott Huckins was appointed CFO of the Company. In connection with his appointment, the Company granted Mr. Huckins options to purchase 262,182 Common Shares, 327,819 RSUs (of which 154,500 were issued to equal the number of Common Shares purchased by Mr. Huckins on the open market prior to December 12, 2019) and 346,638 PSUs. The stock options vest on September 3, 2022, subject to Mr. Huckins' continued employment during the vesting period, and expire on September 3, 2029. Each vested stock option entitles Mr. Huckins to purchase one Common Share at an exercise price of $2.38, which was equal to the closing price of the Common Shares on September 3, 2019. The RSUs vest in three equal annual installments beginning on September 3, 2020, and each vested RSU entitles Mr. Huckins to receive one Common Share of the Company The vesting of 173,319 of the PSUs granted is subject to the Company achieving predetermined annual thresholds of adjusted EBITDA from continuing operations during fiscal years 2019 through 2022, as follows: 57,773 PSUs vest upon the Company achieving annual adjusted EBITDA of $43 million, another 57,773 vest upon the Company achieving annual adjusted EBITDA of $65 million, and the final 57,773 vest upon the Company achieving annual adjusted EBITDA of $87 million, and subject to Mr. Huckins' continued employment with the Company through the end of the fiscal year during which the adjusted EBITDA performance condition is achieved. The vesting of the other 173,319 PSUs that were granted is subject to the Common Shares achieving certain volume-weighted average trading prices during a performance period commencing on September 3, 2019 and ending on December 31, 2022, as follows: 57,773 PSUs vest upon achieving a trading price of $5.00 per share, another 57,773 vest upon achieving a trading price of $9.00 per share, and the final 57,773 vest upon achieving a trading price of $14.00 per share, in each case for 20 consecutive trading days, and subject to Mr. Huckins' continued employment with the Company through the date the stock price performance condition is achieved. Each vested PSU entitles Mr. Huckins to receive one Common Share without payment of additional consideration. The weighted-average grant-date fair values of the RSUs and PSUs subject to the adjusted EBITDA performance condition were estimated to be $2.45 and $2.38, respectively, based on the closing price of Common Shares on the dates of grant. A grant-date fair value of $1.18 was estimated for the stock options using the Black-Scholes option pricing model, and a weighted-average grant-date fair value of $0.79 was estimated for the PSUs subject to the stock price performance condition using a Monte Carlo valuation model. The following table summarizes the inputs to the Black-Scholes option-pricing and Monte Carlo valuation models: Stock Options PSUs Grant-date stock price $ 2.38 $ 2.38 Exercise price $ 2.38 NA Dividend yield 0% 0% Expected volatility (a) 49.7% 55.9% Risk-free interest rate (b) 1.4% 1.4% Expected life (in years) (c) 6.5 2.1 (a) Determined based on the historical volatility of the Common Shares over the expected life of the stock options and performance period of the PSUs. (b) Determined based on U.S. Treasury yields with a remaining term equal to the expected life of the stock options and performance period of the PSUs. (c) Determined based on the mid-point of vesting (three years) and expiration (ten years) for the stock options and the derived service period for the PSUs. In connection with his employment agreement, the Company issued Mr. Huckins an additional 29,090 RSUs during the year ended January 1, 2022, which will vest on each of the first three anniversaries of the date of the grant, subject to Mr. Huckins continued employment with the Company. The grant-date fair value of these additional RSUs was estimated to be $15.49 based on the closing price of the Common Shares on the date of grant. The aggregate grant-date fair value of the stock options, RSUs and PSUs awarded to Mr. Huckins was determined to be $2.1 million, which is being recognized on a straight-line basis over the vesting period for the stock options and RSUs and the derived service period for the PSUs. Each reporting period, the number of PSUs subject to the adjusted EBITDA performance condition that are expected to vest is redetermined and the aggregate grant-date fair value of the redetermined number of those PSUs is amortized over the remaining service period less amounts previously recognized. Total compensation costs related to Mr. Huckins' non-vested equity awards not yet recognized as an expense was $0.7 million as at January 1, 2022, which will be amortized over a weighted-average remaining vesting period of 1.4 years. The following table summarizes activity related to Mr. Huckins' non-vested equity awards during the year ended January 1, 2022: Stock EBITDA Stock price options RSUs PSUs PSUs Non-vested, beginning of year 262,182 218,546 173,319 57,773 Granted - 29,090 - - Vested - (109,273 ) (57,773 ) (57,773 ) Non-vested, end of year 262,182 138,363 115,546 - The total intrinsic value of Mr. Huckins' equity awards that vested during the year ended January 1, 2022 was $2.8 million. Employee Stock Purchase Plan The Company maintains an Employee Stock Purchase Plan whereby employees can purchase common shares through payroll deductions. For the year ended January 1, 2022, the Company's employees purchased 66,834 Common Shares (January 2, 2021 - 113,581; December 28, 2019 - 185,415) for total proceeds of $0.6 million (January 2, 2021 - $0.5 million; December 28, 2019 - $0.5 million). As at January 1, 2022, 634,082 Common Shares are remaining to be granted under this plan.

Other Expense (Income), Net

Other Expense (Income), Net	12 Months Ended
	Jan. 01, 2022
Other Income and Expenses [Abstract]
Other Expense (Income), Net [Text Block]	18. Other Expense (Income), Net The components of other expense (income) are as follows: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Long-lived asset impairments and facility closure costs (1) 6,298 9,045 308 Employee termination and recruitment costs (2) 1,628 1,881 5,548 Divestiture costs (3) 703 - - Settlement loss (gain) (4) 163 179 (3,065 ) Loss on foreign currency forward contract (see note 4) - 12,658 - Gain on sale of soy and corn business (see note 5) - - (44,027 ) Other 98 (370 ) 597 8,890 23,393 (40,639 ) (1) Long-lived asset impairments and facility closure costs For the year ended January 1, 2022, expenses include asset impairment charges and asset relocation costs of $3.8 million related to the closure of the Company's South Gate, California, fruit ingredient processing facility in July 2021, and costs of $1.4 million to complete the exit from the Company's Santa Maria, California, frozen fruit processing facility in February 2021, together with costs of $0.8 million related to the relocation of the Company's executive office and innovation center into Eden Prairie, Minnesota, and the related vacating of the Company's former leased facility in December 2021, and other asset impairments of $0.3 million. For the year ended January 2, 2021, expenses include costs of $6.3 million related to the Company's exit from its Santa Maria facility and the consolidation of the Company's corporate offices into Minnesota, together with the write-down of $2.7 million of operating lease right-of-use and owned assets related to the consolidation of roasting lines at the Company's Crookston, Minnesota, facility. For the year ended December 28, 2019, expenses include costs to dismantle and move equipment from the Company's former soy extraction facility located in Heuvelton, New York, which was sold in April 2019. (2) Employee termination and recruitment costs For the year ended January 1, 2022, expense represents severance benefits of $1.1 million for 55 employees impacted by the closure of the South Gate facility, and $0.5 million of severance benefits for 19 employees following a workforce reduction in the Company's frozen fruit operations. For the year ended January 2, 2021, expense represents severance benefits of $2.8 million mainly related to employees impacted by the exit from the Company's Santa Maria facility, offset by the reversal of $0.9 million of previously recognized stock-based compensation expense related to forfeited awards previously granted to terminated employees. For the year ended December 28, 2019, expenses represent severance benefits of $8.4 million for employees terminated in connection with a workforce reduction program and corporate office consolidation, together with recruitment, relocation and termination costs related to the appointments of a new Chief Executive Officer and new Chief Financial Officer of the Company. These expenses were partially offset by the reversal of $4.1 million of previously recognized stock-based compensation expense related to forfeited awards previously granted to terminated employees. (3) Divestiture costs For the year ended January 1, 2022, expense relates to professional fees incurred in connection with post-closing matters related to the divestiture of Tradin Organic. (4) Settlement loss (gain) For the year ended January 1, 2022, expense represents a $0.5 million loss from the settlement of an employment-related legal matter, partially offset by a gain related to a project cancellation. For the year ended January 2, 2021, the Company recognized a $2.4 million loss from the settlement of a customer claim related to the voluntary recall of certain roasted sunflower kernel products initiated by the Company in 2016, which included a cash settlement payment of $4.4 million, partially offset by the receipt of related insurance proceeds. This loss was offset by gains of $2.2 million recognized from the settlement of unrelated matters. For the year ended December 28, 2019, the Company recognized gains from the settlement of certain legal matters and a project cancellation.

Income Taxes

Income Taxes	12 Months Ended
	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	19. Income Taxes The income tax benefit differs from the amount that would have resulted from applying the combined Canadian federal and provincial statutory income tax rate to loss from continuing operations before income taxes due to the following: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Loss from continuing operations (7,510 ) (50,042 ) (16,181 ) Canadian statutory rate 26.5% 26.5% 26.5% Income tax benefit at statutory rate (1,990 ) (13,261 ) (4,288 ) Stock-based compensation 2,166 3,169 1,975 Change in valuation allowance 975 560 (113 ) Disallowed executive compensation 138 2,801 - Foreign tax rate differential (31 ) (105 ) 126 Change in enacted tax rates (442 ) 250 (549 ) CARES Act - 2,472 - Other (4,182 ) 1,374 (252 ) Income tax benefit (3,366 ) (2,740 ) (3,101 ) The components of earnings (loss) from continuing operations before income taxes are shown below: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Canada (10,797 ) (14,700 ) (11,295 ) U.S. 3,945 (34,521 ) (5,548 ) Other (658 ) (821 ) 662 Loss from continuing operations before income taxes (7,510 ) (50,042 ) (16,181 ) The components of income tax expense (benefit) are shown below: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Current income tax expense (benefit): Canada (9 ) (154 ) (1,023 ) U.S. (75 ) (14,148 ) (3,424 ) Other (359 ) 589 532 (443 ) (13,713 ) (3,915 ) Deferred income tax expense (benefit): Canada 299 (291 ) 33 U.S. (3,067 ) 10,442 731 Other (155 ) 822 50 (2,923 ) 10,973 814 Income tax benefit (3,366 ) (2,740 ) (3,101 ) Deferred income taxes of the Company are comprised of the following: January 1, 2022 January 2, 2021 $ $ Differences in property, plant and equipment and intangible assets (54,761 ) (55,105 ) Capital and non-capital losses 21,540 14,388 Interest expense limitation (163j) 10,521 11,069 Tax benefit of scientific research expenditures 2,744 2,699 Inventory basis differences 1,148 1,303 Other accrued reserves 1,590 4,522 (17,218 ) (21,124 ) Less: valuation allowance 5,267 4,284 Deferred income tax liability (22,485 ) (25,408 ) T he components of the deferred income tax liability are shown below : January 1, 2022 January 2, 2021 $ $ Canada (325 ) (26 ) U.S. (22,083 ) (25,150 ) Other (77 ) (232 ) Deferred income tax liability (22,485 ) (25,408 ) The components of the deferred income tax valuation allowance are as follows: January 1, 2022 January 2, 2021 $ $ Balance, beginning of year 4,284 6,219 Increase (decrease) in valuation allowance 983 (1,935 ) Balance, end of year 5,267 4,284 As at January 1, 2022, the Company had approximately $1.6 million (January 2, 2021 - $1.5 million) in U.S. federal scientific research investment tax credits and $0.9 million (January 2, 2021 - $0.9 million) in U.S. state research and development tax credits, which will expire in varying amounts between 2022 and 2029. As at January 1, 2022, the Company had U.S. federal non-capital loss carryforwards of approximately $64.8 million (January 2, 2021 - $37.1 million). In addition, the Company had state loss carryforwards of approximately $3.3 million as at January 1, 2022 (January 2, 2021 - $8.7 million). These amounts are available to reduce future federal and state income taxes. As at January 1, 2022, the Company had Canadian capital losses of approximately $27.8 million (January 2, 2021 - $27.9 million) for which a full valuation allowance exists. These amounts are available to reduce future capital gains and do not expire. In addition, the Company had Canadian non-capital loss carryforwards of approximately $6.0 million (January 2, 2021 - $2.8 million). These amounts are available to reduce future taxable income and do not begin to expire until 2040. The Company records net deferred tax assets to the extent it believes these assets will more likely than not be realized. In making such determinations, the Company considers all available positive and negative evidence, including future reversals of existing temporary differences, projected future taxable income, tax planning strategies and recent financial operations. Based on this evaluation, as at January 1, 2022, a valuation allowance of $5.3 million (January 2, 2021 - $4.3 million) had been recorded against certain assets to reduce the net benefit recorded in the consolidated financial statements. As the undistributed earnings of the Company's non-Canadian affiliates and associated companies are considered to be indefinitely reinvested, no provision for deferred taxes has been provided thereon. For the years ended January 1, 2022, January 2, 2021 and December 28, 2019, the Company did not identify any material uncertain tax positions or recognize any related tax benefits. The Company believes it has adequately examined its tax positions taken or expected to be taken in a tax return; however, amounts asserted by taxing authorities could differ from the Company's positions. Accordingly, additional provisions on federal, provincial, state, and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved. Consistent with its historical financial reporting, the Company has classified interest and penalties related to income tax liabilities, when applicable, as part of interest expense in its consolidated statements of operations, and with the related liability on the consolidated balance sheets. The number of years with open tax audits varies depending on the tax jurisdiction. The Company's major taxing jurisdictions are the U.S. (including multiple states) and Canada (Ontario). The Company's 2018 through 2020 tax years (and any tax year for which available non-capital loss carryforwards were generated up to the amount of non-capital loss carryforward) remain subject to examination by the Internal Revenue Service for U.S. federal tax purposes, and tax years 2014 through 2020 remain subject to examination by the appropriate governmental agencies for Canadian federal tax purposes. There are other ongoing audits in various other jurisdictions that are not considered material to the Company's consolidated financial statements.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Jan. 01, 2022
Earnings Per Share [Abstract]
Earnings (Loss) Per Share [Text Block]	20. Earnings (Loss) Per Share Basic and diluted earnings (loss) per share were calculated as follows (shares in thousands): January 1, 2022 January 2, 2021 December 28, 2019 Basic Earnings (Loss) Per Share Numerator for basic earnings (loss) per share: Loss from continuing operations $ (4,144 ) $ (47,302 ) $ (13,080 ) Less: dividends and accretion on Series A Preferred Stock (1,212 ) (8,319 ) (8,022 ) Less: dividends and accretion on Series B-1 Preferred Stock (2,985 ) (2,009 ) - Loss from continuing operations attributable to common shareholders (8,341 ) (57,630 ) (21,102 ) Earnings from discontinued operations - 124,820 12,322 Earnings (loss) attributable to common shareholders $ (8,341 ) $ 67,190 $ (8,780 ) Denominator for basic earnings (loss) per share: Basic weighted-average number of shares outstanding 104,098 89,234 87,787 Basic earnings (loss) per share: From continuing operations $ (0.08 ) $ (0.65 ) $ (0.24 ) From discontinued operations - 1.40 0.14 Basic earnings (loss) per share $ (0.08 ) $ 0.75 $ (0.10 ) Diluted Earnings (Loss) Per Share Numerator for diluted earnings (loss) per share: Loss from continuing operations $ (4,144 ) $ (47,302 ) $ (13,080 ) Less: dividends and accretion on Series A Preferred Stock (1,212 ) (8,319 ) (8,022 ) Less: dividends and accretion on Series B-1 Preferred Stock (2,985 ) (2,009 ) - Loss from continuing operations attributable to common shareholders (8,341 ) (57,630 ) (21,102 ) Earnings from discontinued operations - 124,820 12,322 Earnings (loss) attributable to common shareholders $ (8,341 ) $ 67,190 $ (8,780 ) Denominator for diluted earnings (loss) per share: Basic weighted-average number of shares outstanding 104,098 89,234 87,787 Dilutive effect of the following: Stock options and restricted stock units (1) - - - Series B-1 Preferred Stock (2) - - - Series A Preferred Stock (3) - - - Diluted weighted-average number of shares outstanding 104,098 89,234 87,787 Diluted earnings (loss) per share: From continuing operations $ (0.08 ) $ (0.65 ) $ (0.24 ) From discontinued operations - 1.40 0.14 Diluted earnings (loss) per share $ (0.08 ) $ 0.75 $ (0.10 ) (1) (2) (3) As described in note 15, on February 22, 2021, all shares of Series A Preferred Stock were exchanged for 12,633,427 Common Shares, representing 12.3% of the Company's issued and outstanding Common Shares on a post-exchange basis as at February 22, 2021. For the years ended January 2, 2021 and December 28, 2019, it was more dilutive to the loss per share from continuing operations to assume the Series A Preferred Stock was not converted into Common Shares and, therefore, the numerator of the diluted earnings (loss) per share calculation was not adjusted to add back the dividends and accretion on the Series A Preferred Stock and the denominator was not adjusted to include 12,633,427 and 11,333,333 Common Shares issuable on an if-converted basis as at January 2, 2021 and December 28, 2019, respectively.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Jan. 01, 2022
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information [Text Block]	21. Supplemental Cash Flow Information January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Changes in Operating Assets and Liabilities, Net of Businesses Sold Accounts receivable (11,978 ) (746 ) 4,013 Inventories (72,395 ) 6,133 7,097 Accounts payable and accrued liabilities 16,195 11,322 (5,861 ) Other operating assets and liabilities 4,423 422 (4,518 ) (63,755 ) 17,131 731 Non-Cash Investing and Financing Activities Change in additions to property, plant and equipment included in accounts payable and accrued liabilities 3,482 2,043 (2,886 ) Change in accrued dividends on preferred stock (1,769 ) 679 - Dividends paid in kind on preferred stock (see note 15) - 3,881 - Change in accrued transaction costs related to the divestiture of Tradin Organic (see note 13) (1) (13,380 ) 13,380 - Change in accrued debt issuance costs (see note 13) (1,690 ) 1,690 - Cash Paid Interest 6,610 30,740 30,399 Income taxes 3,632 935 410 (1) For the year ended January 1, 2022, the settlement of transaction costs related to the divestiture of Tradin Organic is included in investing activities of discontinued operations on consolidated statement of cash flows.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Jan. 01, 2022
Related Party Transactions [Abstract]
Related Party Transactions [Text Block]	22. Related Party Transactions During the years ended January 2, 2021 and December 28, 2019, the Company purchased certain raw fruit, and fruit processing and freight services from companies related to the former Managing Director of the Company's Mexican operations, who left the Company in 2020. These transactions totaled $15.0 million and $29.7 million for years ended January 2, 2021 and December 28, 2019, respectively, and were included in cost of goods sold on the consolidated statements of operations. In addition, as at January 1, 2022 and January 2, 2021, the Company had outstanding loans of $2.0 million made to the former Managing Director while employed by the Company, to provide operating funds for farms owed by the former director. The Company has initiated legal proceedings to recover these loans and considers the amount to be fully collectible. The Company had no other significant related party transactions for the years January 1, 2022, January 2, 2021 and December 28, 2019.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jan. 01, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies [Text Block]	23. Commitments and Contingencies Legal Proceedings Various current and potential claims and litigation arising in the ordinary course of business are pending against the Company. The Company believes it has established adequate accruals for liabilities that are probable and reasonably estimable that may be incurred in connection with any such currently pending matter. In the Company's opinion, the eventual resolution of such matters, either individually or in the aggregate, is not expected to have a material impact on the Company's financial position, results of operations, or cash flows. However, litigation is inherently unpredictable and resolutions or dispositions of claims or lawsuits by settlement or otherwise could have an adverse impact on the Company's financial position, results of operations, and cash flows for the reporting period in which any such resolution or disposition occurs. Arbitration Proceedings On January 31, 2022, Acomo submitted a Request for Summary Arbitral Proceedings to the Netherlands Arbitration Institute, which was later amended on February 16, 2022, asserting alleged claims against the Company and its subsidiaries, Coöperatie SunOpta U.A. and SunOpta Holdings LLC, relating to a dispute regarding the allocation of the purchase price Acomo paid to acquire the shares of The Organic Corporation B.V. and the membership interests of Tradin Organics USA LLC in connection with the closing of the transactions contemplated by the Master Purchase Agreement entered into by Acomo, the Company and the aforementioned subsidiaries on November 25, 2020. Acomo's claims include requests for the Company to: (i) act in accordance with (a) the purchase price allocation allegedly established with third-party expert advice and (b) the proposed tax allocation; (ii) correct or revise the Company's 2020 U.S. federal income tax return in accordance with the purchase price allocation allegedly established with third-party expert advice and the proposed tax allocation; and (iii) provide information regarding the Company's 2020 U.S. federal income tax return. The Company disagrees with Acomo's position regarding the purchase price allocation and the proposed tax allocation and intends to vigorously defend itself against these claims. The Company cannot reasonably predict the outcome of these claims, nor can it estimate the amount of loss, or range of loss, if any, that may result from these claims. Environmental Laws The Company believes that, with respect to both its operations and real property, it is in material compliance with current environmental laws. Based on known existing conditions and the Company's experience in complying with emerging environmental issues, the Company is of the view that future costs relating to environmental compliance will not have a material adverse effect on its consolidated financial position, but there can be no assurance that unforeseen changes in the laws or enforcement policies of relevant governmental bodies, the discovery of changed conditions on the Company's real property or in its operations, or changes in the use of such properties and any related site restoration requirements, will not result in the incurrence of significant costs. Finance Lease Commitments On . The build-out lease has an implicit rate of interest of 6.82% and a term of 48 months following completion of construction. The Company may purchase the build-out assets for a nominal amount at the end of the lease term. On September 7, 2021, the Company entered into two finance lease agreements providing for up to $50 million of total financing for equipment and leasehold improvements to be installed in connection with the build-out of the Company's new plant-based beverage facility under construction in Midlothian, Texas. Once the construction of the building is completed by the landlord and is made available for use by the Company, which is expected to occur in 2022, the facility will be occupied under a 15-year operating lease, with three five-year extension options. The build-out leases do not include the manufacturing equipment for the facility (described below under "Commitments for Plant Acquisition"). T he Company recognizes costs incurred related to the build-out as construction in process in property, plant and equipment, with a finance lease liability recognized in long-term debt for the amount funded to-date under the build-out leases, which amounted to $4.9 million as at . The build-out leases have an implicit rate of interest of 6.45% and a term of 48 months following completion of construction. The Company may purchase the build-out assets for a nominal amount at the end of the lease term. As at January 1, 2022, the Company had additional commitments under various finance leases that provide for up to approximately $23 million of financing for expansion projects within the Company's plant-based operations, which are expected to become operational during 2022. As these finance leases had not commenced as at January 1, 2022, no amount of underlying right-of-use assets, or lease liabilities, were recognized on the consolidated balance sheet as of that date. Commitments for Plant Acquisition As at January 1, 2022, the Company had approximately $52 million of contractual commitments related to the purchase of manufacturing equipment for its Midlothian, Texas, facility, of which approximately $14 million was paid or payable as at January 1, 2022, with the balance of $38 million expected to be incurred during 2022. These commitments are being principally financed through borrowings under the Term Loan Facility of the Company's Asset-Based Credit Facilities. Letters of Credit As at January 1, 2022, the Company had outstanding letters of credit totaling $7.3 million.

Sunflower Purchases

Sunflower Purchases	12 Months Ended
	Jan. 01, 2022
Sunflower Purchases [Abstract]
Sunflower Purchases [Text Block]	24. Sunflower Purchases For the year ended January 1, 2022, the Company's subsidiary, SunOpta Grains and Foods Inc., purchased $24.1 million and $17.4 million of sunflower seeds from growers located in Minnesota and North Dakota, respectively.

Segment Information

Segment Information	12 Months Ended
	Jan. 01, 2022
Segment Reporting [Abstract]
Segment Information [Text Block]	25. Segment Information The composition of the Company's operating segments is as follows: Plant-Based Foods and Beverages includes plant-based beverages and liquid and powder ingredients (utilizing oat, almond, rice, soy, coconut, hemp, and other bases), as well as broths, teas, and nutritional beverages. In addition, Plant-Based Foods and Beverages includes packaged dry- and oil-roasted inshell sunflower and sunflower kernels, and the processing and sale of raw sunflower inshell and kernel for food and feed applications. Fruit-Based Foods and Beverages includes individually quick frozen ("IQF") fruit for retail (including strawberries, blueberries, mango, pineapple, and other berries and blends), IQF and bulk frozen fruit for foodservice (including toppings, purées, and smoothies). In addition, Fruit-Based Foods and Beverages includes fruit snacks, including bars, twists, ropes, and bite-sized varieties, and recently introduced fruit-based smoothie bowls. In connection with the Company's exit from its fruit ingredient processing facility in July 2021 (see note 18), the Company ceased the production of custom fruit preparations for industrial use. The Global Ingredients segment information presented below reflects the Company's soy and corn business prior to its sale on February 22, 2019 (see note 5). Corporate Services provides a variety of management, financial, information technology, treasury, and administration services to each of the Company's operating segments. When reviewing the operating results of the Company's operating segments, management uses segment revenues from external customers and segment operating income/loss to assess performance and allocate resources. Total segment operating income/loss includes general and administrative expenses incurred by Corporate Services and excludes other income/expense items and goodwill impairments. In addition, interest on corporate debt and income taxes are not allocated to the operating segments. Segment Revenues and Operating Income Reportable segment operating results for the years ended January 1, 2022, January 2, 2021 and December 28, 2019 were as follows: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Segment revenues from external customers Plant-Based Foods and Beverages 470,754 415,164 361,398 Fruit-Based Foods and Beverages 341,870 374,049 349,852 Global Ingredients - - 10,346 Total revenues from external customers 812,624 789,213 721,596 Segment operating income (loss) Plant-Based Foods and Beverages 36,981 50,780 29,476 Fruit-Based Foods and Beverages (9,320 ) (7,321 ) (26,873 ) Global Ingredients - - (187 ) Corporate Services (17,512 ) (31,151 ) (26,471 ) Total segment operating income 10,149 12,308 (24,055 ) Other income (expense), net (see note 18) (8,890 ) (23,393 ) 40,639 Interest expense, net (see note 14) (8,769 ) (30,042 ) (32,765 ) Loss on retirement of debt (see note 14) - (8,915 ) - Loss from continuing operations before income taxes (7,510 ) (50,042 ) (16,181 ) Segment Assets Total assets by reportable segment as at January 1, 2022 and January 2, 2021 were as follows: January 1, 2022 January 2, 2021 $ $ Segment Assets Plant-Based Foods and Beverages 301,065 191,580 Fruit-Based Foods and Beverages 368,976 329,151 Corporate Services 85,078 64,884 Total assets 755,119 585,615 Segment Capital Expenditures, Depreciation and Amortization Capital expenditures, depreciation and amortization by reportable segment for the years ended January 1, 2022, January 2, 2021 and December 28, 2019 were as follows: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Segment Capital Expenditures Plant-Based Foods and Beverages 38,760 11,323 15,289 Fruit-Based Foods and Beverages 5,926 10,378 9,689 Global Ingredients - - 92 Corporate Services 13,611 3,053 3,317 Total capital expenditures 58,297 24,754 28,387 Segment Depreciation and Amortization Plant-Based Foods and Beverages 14,942 9,457 7,799 Fruit-Based Foods and Beverages 14,918 16,304 16,702 Global Ingredients - - 129 Corporate Services 4,781 4,547 4,636 Total depreciation and amortization 34,641 30,308 29,266 Geographic Information The Company's assets, operations, and employees are located in the U.S., Mexico, and Canada. Revenues from external customers are attributed to countries based on the location of the customer. Revenues from external customers by geographic area for the years ended January 1, 2022, January 2, 2021 and December 28, 2019 were as follows: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Revenues from External Customers U.S. 772,333 752,000 691,838 Canada 14,067 12,481 9,418 Other 26,224 24,732 20,340 Total revenues from external customers 812,624 789,213 721,596 Long-lived assets consist of property, plant and equipment, net of accumulated depreciation, which are attributed to countries based on the physical location of the assets. Long-lived assets by geographic area as at January 1, 2022 and January 2, 2021 were as follows: January 1, 2022 January 2, 2021 $ $ Long-Lived Assets U.S. 203,318 144,555 Mexico 14,124 11,511 Canada 2,095 1,982 Total long-lived assets 219,537 158,048 Major Customers A customer of the Plant-Based Foods and Beverages operating segment accounted for approximately 18%, 16% and 18% of the Company's consolidated revenues for the years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively, and a customer of both the Fruit-Based and Plant-Based Foods and Beverages operating segments accounted for approximately 12%, 14% and 11% of consolidated revenues for the years ended January 1, 2022, January 2, 2021 and December 28, 2019, respectively. No other customer accounted for more than 10% of the Company's consolidated revenues.

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation [Policy Text Block]	Basis of Presentation These consolidated financial statements include the accounts of SunOpta Inc. and those of its wholly-owned subsidiaries (collectively, the "Company" or "SunOpta") and have been prepared by the Company in United States ("U.S.") dollars and in accordance with U.S. generally accepted accounting principles ("U.S. GAAP"). All intercompany accounts and transactions have been eliminated on consolidation.
Fiscal Year [Policy Text Block]	Fiscal Year The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal year 2021 was a 52-week period ending on January 1, 2022, fiscal year 2020 was a 53-week period ending on January 2, 2021, and fiscal year 2019 was a 52-week period ending on December 28, 2019. Fiscal year 2022 will be a 52-week period ending on December 31, 2022, with quarterly periods ending on April 2, 2022, July 2, 2022, and October 1, 2022.
Use of estimates [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Areas involving significant estimates and assumptions include: allowances for credit losses; inventory reserves; income tax liabilities and assets, and related valuation allowances; provisions for loss contingencies related to claims and litigation; useful lives of property, plant and equipment and intangible assets; expected lease terms and discount rates in measuring lease assets and liabilities; expected future cash flows used in evaluating long-lived assets for impairment; and reporting unit fair values in testing goodwill for impairment. The estimates and assumptions made require judgment on the part of management and are based on the Company's historical experience and various other factors that are believed to be reasonable in the circumstances. Management continually evaluates the information that forms the basis of its estimates and assumptions as the business of the Company and the general business environment changes.
Fair Value [Policy Text Block]	Fair Value Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (that is, an exit price). Fair value measurements are estimated based on inputs categorized as follows: • Level 1 inputs include quoted prices (unadjusted) for identical assets or liabilities in active markets that are observable. • Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means. • Level 3 includes unobservable inputs that reflect the Company's own assumptions about what factors market participants would use in pricing the asset or liability. When measuring fair value, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs.
Foreign Currency Translation [Policy Text Block]	Foreign Currency Translation Exchange gains and losses on transactions occurring in a currency other than an operation's functional currency are recognized in earnings. Foreign currency gains and losses related to the remeasurement of the Company's Mexican operations into its U.S. dollar functional currency are recognized in earnings.
Cash and Cash Equivalents [Policy Text Block]	Cash and Cash Equivalents Cash and cash equivalents consist of cash and short-term deposits with an original maturity of 90 days or less. The Company places its cash and cash equivalents with institutions of high creditworthiness.
Accounts Receivable [Policy Text Block]	A ccounts Receivable Accounts receivable includes trade receivables that are recorded at the invoiced amount and do not bear interest. The allowance for credit losses is an estimate of the amount of probable losses in existing accounts receivable. The Company routinely assesses the financial strength of its customers and believes that its accounts receivable credit risk exposure is limited. The Company closely monitors receivable balances and estimates an allowance for credit losses based on historical collection experience, and account aging analysis and trends, and evaluates the adequacy of the allowance each reporting period, considering individual customer account reviews, write-offs recorded in the period, sales forecasts and trends, and current and expected economic and customer-specific conditions. Account balances are charged off against the allowance when the Company determines the receivable will not be recovered. As at January 1, 2022, three long-term customers represented approximately 14%, 13% and 12%, respectively, of the Company's consolidated trade receivables balance. The Company does not believe it is exposed to any significant credit risks with respect to these customers.
Inventories [Policy Text Block]	Inventories Inventories are valued at the lower of cost and net realizable value. Shipping and handling costs are included in cost of goods sold on the consolidated statements of operations.
Property, Plant and Equipment [Policy Text Block]	Property, Plant and Equipment Property, plant and equipment assets are stated at cost, less accumulated depreciation. Cost includes capitalized interest on borrowings during the construction of major capital projects. Depreciation begins when an asset is ready for its intended use. Property, plant and equipment assets, other than land, are depreciated on a straight-line basis over the estimated useful lives of the assets, as follows: Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years
Leases [Policy Text Block]	Leases At the lease commencement date, the Company recognizes a right-of-use lease asset for an amount equal to the lease liability, less any lease incentives. The lease liability is determined based on the present value of future lease payments over the lease term. The discount rate used to determine the present value of the future lease payments is the implicit rate in the lease if readily determinable. When that rate is not readily determinable, the Company applies its incremental borrowing rate, which its estimated using relevant interest rate yield curves and credit spreads derived from available market data and the Company's corporate credit rating. The Company excludes material non-lease components in determining the future lease payments. Material leases with an initial term of 12 months or less are recorded on the balance sheet.
Intangible Assets [Policy Text Block]	Intangible Assets The Company's finite-lived intangible assets primarily consist of customer relationships and brand names. Intangible assets are amortized on a straight-line basis over their estimated useful lives, which are 10 to 25 years for customer relationships and 15 years for brand names.
Impairment of Long-Lived Assets [Policy Text Block]	Impairment of Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If the carrying amount of an asset is not recoverable, the fair value of the asset is determined typically using an income approach (discounted cash flow analysis). An impairment loss is recognized in earnings for any excess of the carrying amount of the asset over its fair value.
Goodwill [Policy Text Block]	Goodwill Goodwill represents the excess in a business combination of the purchase price over the estimated fair value of the identifiable net assets acquired. Goodwill is not amortized but is instead tested for impairment at the reporting unit level at least annually, or whenever events or circumstances change between the annual impairment tests that would indicate the carrying amount of goodwill may be impaired. The Company performs its annual test for goodwill impairment in the fourth quarter of each fiscal year. The Company can elect to qualitatively assess goodwill for impairment if it is more likely than not that the fair value of a reporting unit exceeds its carrying value. If the Company elects to quantitatively assess goodwill, or it is not more likely than not that the fair value of a reporting unit exceeds its carrying value, the Company estimates the fair value of each of its reporting units using an income approach (discounted cash flow method). Goodwill impairment charges are recognized based on the excess of a reporting unit's carrying amount over its fair value. The results of the Company's annual impairment tests for goodwill are described in note 12.
Derivative Instruments [Policy Text Block]	Derivative Instruments From time to time, the Company utilizes foreign currency forward contracts to manage its exposure to exchange rate fluctuations relating to foreign currency denominated inventory purchases and operating costs. Contracts are entered into for periods consistent with related underlying exposures and do not constitute positions independent of those exposures. The Company does not enter into contracts for speculative purposes. Foreign currency forward contracts are recognized on the consolidated balance sheets at fair value. Gains or losses in the fair value of foreign currency forward contracts not specifically designated as hedging instruments are included in foreign exchange gain/loss on the consolidated statements of operations. For contracts designated as accounting hedges, gains or losses in fair value are recognized in other comprehensive earnings and subsequently recognized in earnings in the same period the hedged item affects earnings. The ineffective portion of an accounting hedge is recognized immediately in earnings.
Debt Issuance Costs [Policy Text Block]	Debt Issuance Costs Costs incurred in connection with obtaining debt financing are deferred and amortized over the term of the financing arrangement using the effective interest method. Costs incurred to secure revolving credit facilities are recorded in other long-term assets. All other debt issuance costs are recorded as a direct deduction from the related debt liability.
Income Taxes [Policy Text Block]	Income Taxes The Company follows the asset and liability method of accounting for income taxes whereby deferred income tax assets are recognized for deductible temporary differences and operating loss carryforwards, and deferred income tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the amounts of assets and liabilities recorded for income tax and financial reporting purposes. Deferred income tax assets are recognized only to the extent that management determines that it is more likely than not that the deferred income tax assets will be realized. Deferred income tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. The income tax expense or benefit is the income tax payable or recoverable for the year plus or minus the change in deferred income tax assets and liabilities during the year. The Company is subject to ongoing tax exposures, examinations and assessments in various jurisdictions. Accordingly, the Company may incur additional income tax expense based upon the outcomes of such matters. In addition, when applicable, the Company adjusts income tax expense to reflect the Company's ongoing assessments of such matters, which requires judgment and can materially increase or decrease its effective rate as well as impact operating results. The evaluation of tax positions taken or expected to be taken in a tax return is a two-step process, whereby (i) the Company determines whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position, and (ii) for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority.
Stock Incentive Plan [Policy Text Block]	Stock Incentive Plan The Company maintains a stock incentive plan under which stock options and other stock-based awards may be granted to selected employees and directors. The Company measures stock-based awards at fair value as of the date of grant. Compensation expense is recognized on a straight-line basis over vesting period of the entire stock-based award, based on the number of awards that ultimately vest. Upon exercise, stock-based awards are settled through the issuance of common shares and are therefore treated as equity awards.
Revenue Recognition [Policy Text Block]	Revenue Recognition Revenue is recognized when the Company transfers control of promised goods to its customers in an amount that reflects the consideration to which the Company expects to be entitled to in exchange for those goods. See note 2 for further discussion related to revenue recognition.
Earnings Per Share [Policy Text Block]	Earnings Per Share Basic earnings per share is computed by dividing earnings available to common shareholders by the weighted-average number of common shares outstanding during the year. Earnings available to common shareholders is computed by deducting dividends and accretion on convertible preferred stock from earnings attributable to SunOpta Inc. The potential diluted effect of stock options and other stock-based awards is computed using the treasury stock method whereby the weighted-average number of common shares used in the basic earnings per share calculation is increased to include the number of additional common shares that would have been outstanding if the potential dilutive common shares had been issued at the beginning of the year. The potential dilutive effect of convertible preferred stock is computed using the if-converted method whereby dividends and accretion on the convertible preferred stock are added back to the numerator, and the common shares resulting from the assumed conversion of the convertible preferred stock are included in the denominator of the diluted earnings per share calculation.
Contingencies [Policy Text Block]	Contingencies In the normal course of business, the Company is subject to loss contingencies, such as accrued but unpaid bonuses, tax-related matters, and claims or litigation. Accruals for loss contingencies are recorded when the Company determines that it is both probable that a liability has been incurred and the amount of loss can be reasonably estimated. If the estimate of the amount of the loss is a range and some amount within the range appears to be a better estimate than any other amount within the range, that amount is accrued as a liability. If no amount within the range is a better estimate than any other amount, the minimum amount of the range is accrued as a liability. The Company recognizes an asset for insurance recoveries when a loss event has occurred and recovery is considered probable, to the extent that the potential recovery does not exceed the loss recognized.
Recent Accounting Pronouncements [Policy Text Block]	Recent Accounting Pronouncements In March 2020 and January 2021, the Financial Accounting Standards Board issued Accounting Standard Updates 2020-04 and 2021-01, Reference Rate Reform (Topic 848), that provide temporary optional expedients and exceptions to the U.S. GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burden related to the transition away from LIBOR and other reference rates that are expected to be discontinued. The guidance in Topic 848 is effective upon issuance and can be applied prospectively for contract modifications and hedging relationships through December 31, 2022. The Company does not expect the guidance will have a material effect on its consolidated financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of useful life for property plant and equipment [Table Text Block]	Buildings 20 - 40 years Machinery and equipment 5 - 20 years Enterprise software 3 - 5 years Office furniture and equipment 3 - 7 years Vehicles 3 - 7 years

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Jan. 01, 2022
Revenue from Contract with Customer [Abstract]
Schedule of disaggregation of revenue [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Plant-Based Foods and Beverages Beverages and broths 376,525 332,390 286,381 Plant-based ingredients 31,135 28,156 22,944 Sunflower and roasted snacks 63,094 54,618 52,073 Total Plant-Based Foods and Beverages 470,754 415,164 361,398 Fruit-Based Foods and Beverages Frozen fruit and fruit-based ingredients (1) 279,128 325,102 306,060 Fruit snacks 62,742 48,947 43,792 Total Fruit-Based Foods and Beverages 341,870 374,049 349,852 Global Ingredients Soy and corn (2) - - 10,346 Total Global Ingredients - - 10,346 Total revenues 812,624 789,213 721,596

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Jan. 01, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of discontinued operations to amounts reported in the consolidated statements of operations [Table Text Block]	January 2, 2021 December 28, 2019 $ $ Revenues 503,036 468,426 Cost of goods sold 441,277 418,676 Selling, general and administrative expenses (1) 26,953 27,737 Intangible asset amortization 1,451 1,859 Other expense (income), net (782 ) 591 Foreign exchange loss (gain) 3,142 (1,147 ) Interest expense (2) 2,409 1,912 Earnings before gain of sale 28,586 18,798 Pre-tax gain on sale 111,818 - Earnings from discontinued operations before income taxes 140,404 18,798 Income tax expense 15,885 6,322 Earnings (loss) attributable to non-controlling interests (301 ) 154 Earnings from discontinued operations 124,820 12,322

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
	Jan. 01, 2022
Receivables [Abstract]
Schedule of trade receivables [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Trade receivables 85,591 73,981 Allowance for credit losses (889 ) (1,257 ) 84,702 72,724
Schedule of allowance for doubtful accounts [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Balance, beginning of year 1,257 630 Net addition (reduction) to provision (368 ) 627 Balance, end of year 889 1,257

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Jan. 01, 2022
Inventory Disclosure [Abstract]
Schedule of inventory, current [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Raw materials and work-in-process 143,381 78,210 Finished goods 81,546 75,280 Inventory reserve (4,784 ) (5,742 ) 220,143 147,748
Schedule of inventory reserve [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Balance, beginning of year 5,742 8,135 Additions to reserve during the year 5,854 3,081 Reserves applied and inventories written off during the year (6,812 ) (5,474 ) Balance, end of year 4,784 5,742

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	12 Months Ended
	Jan. 01, 2022
Property, Plant and Equipment [Abstract]
Schedule of property, plant and equipment [Table Text Block]	January 1, 2022 January 2, 2021 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Land 6,963 - 6,963 7,009 - 7,009 Buildings 94,935 22,510 72,425 75,308 23,587 51,721 Machinery and equipment 236,779 107,319 129,460 191,831 103,092 88,739 Enterprise software 19,900 11,740 8,160 25,250 16,009 9,241 Office furniture and equipment 5,429 3,130 2,299 7,258 6,157 1,101 Vehicles 1,445 1,215 230 1,850 1,613 237 365,451 145,914 219,537 308,506 150,458 158,048

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jan. 01, 2022
Leases [Abstract]
Schedule of lease costs [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Lease Costs Operating lease cost 13,806 16,647 18,192 Finance lease cost: Depreciation of right-of-use assets 5,922 2,647 1,439 Interest on lease liabilities 2,752 675 267 Sublease income (281 ) (504 ) (476 ) Net lease cost 22,199 19,465 19,422
Schedule of Balance Sheet Classification, Cash Flow Information, Other Information [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Balance Sheet Classification Operating leases: Operating lease right-of-use assets 47,245 35,172 Current portion of operating lease liabilities 12,203 12,750 Operating lease liabilities 39,028 24,582 Total operating lease liabilities 51,231 37,332 Finance leases: Property, plant and equipment, gross 66,060 24,534 Accumulated depreciation (10,348 ) (5,787 ) Property, plant and equipment, net 55,712 18,747 Current portion of long-term debt 9,760 3,146 Long-term debt 43,034 15,667 Total finance lease liabilities 52,794 18,813 January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Cash Flow Information Cash paid (received) for amounts included in measurement of lease liabilities: Operating cash flows from operating leases 13,391 16,741 18,405 Operating cash flows from finance leases 2,752 675 267 Financing cash flows from finance leases (1) (4,828 ) 2,587 1,123 Right-of-use assets obtained in exchange for lease liabilities: Operating leases 29,015 5,962 2,760 Finance leases 29,906 5,179 14,549 Right-of-use assets and liabilities reduced through lease terminations or modifications: Operating leases (2,261 ) (23,667 ) - Finance leases (686 ) - - Impairment of operating lease right-of-use assets - (1,538 ) - (1) For the year ended January 1, 2022, net cash received for amounts included in financing cash flows from finance leases reflected cash advances of $13.6 million received by the Company under finance leases that have not commenced that relate to the construction of right-of-use assets controlled by the Company, partially offset by cash repayments of $8.8 million made by the Company related to finance leases that have commenced. January 1, 2022 January 2, 2021 December 28, 2019 Other Information Weighted-average remaining lease term (years): Operating leases 7.4 3.4 6.1 Finance leases 4.3 5.3 5.9 Weighted-average discount rate: Operating leases 5.0% 6.6% 9.2% Finance leases 6.6% 5.4% 4.5%
Schedule of lease liabilities maturities [Table Text Block]	Operating leases Finance leases $ $ Maturities of Lease Liabilities 2022 10,728 11,965 2023 10,184 14,035 2024 8,264 13,971 2025 6,245 14,665 2026 5,236 6,824 Thereafter 21,638 - Total lease payments 62,295 61,460 Less: imputed interest (11,064 ) (8,666 ) Total lease liabilities 51,231 52,794

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Jan. 01, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	January 1, 2022 January 2, 2021 Cost Accumulated Net book Cost Accumulated Net book $ $ $ $ $ $ Customer relationships 189,407 64,867 124,540 189,407 56,090 133,317 Brand names (see note 3) 25,073 1,173 23,900 - - - Other 1,919 1,919 - 1,919 1,919 - 216,399 67,959 148,440 191,326 58,009 133,317
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2022 2023 2024 2025 2026 Thereafter Total $ $ $ $ $ $ $ Amortization expense 10,448 10,448 10,448 10,448 10,138 96,510 148,440

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	12 Months Ended
	Jan. 01, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Accounts payable 105,386 73,204 Payroll and benefits 8,861 25,423 Accrued interest 846 41 Dividends payable on preferred stock (see note 15) 609 2,378 Accrued costs to sell related to Tradin Organic divestiture - 13,380 Accrued debt issuance costs - 1,690 Other accruals 5,728 2,476 121,430 118,592

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Jan. 01, 2022
Debt Disclosure [Abstract]
Schedule of Line of Credit Facilities [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Asset-based credit facilities: Revolving credit facilities 153,293 47,277 Term loan facility 11,606 — Total asset-based credit facilities 164,899 47,277 Finance lease liabilities (see note 10) 52,794 18,813 Other 6,910 3,633 Total debt 224,603 69,723 Less: current portion 9,760 3,478 Total long-term debt 214,843 66,245
Schedule of Maturities of Long-term Debt [Table Text Block]	$ 2022 11,965 2023 15,417 2024 15,629 2025 176,524 2026 10,711 Thereafter 3,023 Total gross maturities 233,269 Less: imputed interest (8,666 ) Total debt 224,603
Schedule of Interest Expense and Interest Income [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Interest expense 7,685 26,816 30,950 Amortization of debt issuance costs 1,353 4,078 2,721 Interest income (269 ) (852 ) (906 ) Interest expense, net 8,769 30,042 32,765

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Jan. 01, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of allocation of share-based compensation expense [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Selling, general and administrative expenses 9,100 12,570 10,471 Other income (1) — (894 ) (4,131 ) Earnings from discontinued operations (2) — 540 1,145 Total stock-based compensation expense 9,100 12,216 7,485
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock option activity [Table Text Block]	Weighted- average Weighted- remaining average contractual Aggregate Stock options exercise price term (years) intrinsic value Outstanding, beginning of year 2,170,780 $ 6.95 Granted 142,499 14.77 Exercised (920,526 ) 7.18 Forfeited (333,375 ) 7.56 Outstanding, end of year 1,059,378 $ 7.75 6.5 $ 1,219 Exercisable, end of year 665,988 $ 7.46 5.2 $ 653 Weighted- average grant- Stock options date fair value Non-vested, beginning of year 554,987 $ 2.54 Granted 142,499 8.10 Vested (208,477 ) 2.49 Forfeited (95,619 ) 3.26 Non-vested, end of year 393,390 $ 4.49
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 Grant-date stock price $14.77 $4.64 $3.57 Dividend yield (a) 0% 0% 0% Expected volatility (b) 61.7% 60.0% 48.6% Risk-free interest rate (c) 1.0% 0.4% 2.3% Expected life of options (years) (d) 6.0 6.0 5.8
Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	Weighted- average remaining Weighted- Weighted- Exercise price range Outstanding contractual life average exercise Exercisable average exercise Low High options (years) price options price $ 3.25 $ 4.72 97,860 6.5 $ 3.58 87,060 $ 3.44 4.73 5.00 361,385 8.5 4.73 117,917 4.73 5.01 9.48 146,978 3.1 6.70 144,978 6.71 9.49 9.79 218,470 5.4 9.50 218,470 9.50 9.80 14.77 234,685 6.6 13.17 97,563 10.93 1,059,378 6.5 $ 7.75 665,988 $ 7.46
Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]	The following table summarizes non-vested RSU activity during the year ended January 1, 2022: Weighted- average grant- RSUs date fair value Non-vested, beginning of year 647,299 $ 3.39 Granted 245,848 13.32 Vested (285,554 ) 3.93 Forfeited (101,582 ) 3.78 Non-vested, end of year 506,011 $ 7.71
Performance Share Unit ("PSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	Grant-date stock price $ 14.77 Dividend yield 0% Expected volatility (a) 76.9% Risk-free interest rate (b) 0.3% Expected life (in years) (c) 2.7
Schedule of non-vested PSU activity [Table Text Block]	The following table summarizes non-vested EBITDA PSU activity during the year ended January 1, 2022: Weighted- average grant- EBITDA PSUs date fair value Non-vested, beginning of year 3,004,675 $ 3.56 Granted 666,332 13.90 Vested (2,813,175 ) 3.53 Forfeited (187,661 ) 11.40 Non-vested, end of year 670,171 $ 11.77
Total Shareholder Return Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	Weighted- average grant- TSR PSUs date fair value Non-vested, beginning of year - $ - Granted 74,428 23.40 Vested - - Forfeited (3,082 ) 23.40 Non-vested, end of year 71,346 $ 23.40
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	Stock Options PSUs Grant-date stock price $ 3.36 $ 3.36 Exercise price $ 3.36 NA Dividend yield 0% 0% Expected volatility (a) 47.9% 55.7% Risk-free interest rate (b) 2.4% 2.3% Expected life (in years) (c) 6.5 1.8
Schedule of non-vested equity awards [Table Text Block]	Stock EBITDA Stock price options RSUs PSUs PSUs Non-vested, beginning of year 960,061 341,746 892,857 297,619 Vested - (170,873 ) (297,619 ) (297,619 ) Non-vested, end of year 960,061 170,873 595,238 -
Chief Financial Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of stock options granted using the Black-Scholes option pricing model [Table Text Block]	Stock Options PSUs Grant-date stock price $ 2.38 $ 2.38 Exercise price $ 2.38 NA Dividend yield 0% 0% Expected volatility (a) 49.7% 55.9% Risk-free interest rate (b) 1.4% 1.4% Expected life (in years) (c) 6.5 2.1
Schedule of non-vested equity awards [Table Text Block]	Stock EBITDA Stock price options RSUs PSUs PSUs Non-vested, beginning of year 262,182 218,546 173,319 57,773 Granted - 29,090 - - Vested - (109,273 ) (57,773 ) (57,773 ) Non-vested, end of year 262,182 138,363 115,546 -

Other Expense (Income), Net (Ta

Other Expense (Income), Net (Tables)	12 Months Ended
	Jan. 01, 2022
Other Income and Expenses [Abstract]
Schedule of Other Nonoperating Income (Expense) [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Long-lived asset impairments and facility closure costs (1) 6,298 9,045 308 Employee termination and recruitment costs (2) 1,628 1,881 5,548 Divestiture costs (3) 703 - - Settlement loss (gain) (4) 163 179 (3,065 ) Loss on foreign currency forward contract (see note 4) - 12,658 - Gain on sale of soy and corn business (see note 5) - - (44,027 ) Other 98 (370 ) 597 8,890 23,393 (40,639 )

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jan. 01, 2022
Income Tax Disclosure [Abstract]
Schedule of components of income tax expense (benefit) [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Loss from continuing operations (7,510 ) (50,042 ) (16,181 ) Canadian statutory rate 26.5% 26.5% 26.5% Income tax benefit at statutory rate (1,990 ) (13,261 ) (4,288 ) Stock-based compensation 2,166 3,169 1,975 Change in valuation allowance 975 560 (113 ) Disallowed executive compensation 138 2,801 - Foreign tax rate differential (31 ) (105 ) 126 Change in enacted tax rates (442 ) 250 (549 ) CARES Act - 2,472 - Other (4,182 ) 1,374 (252 ) Income tax benefit (3,366 ) (2,740 ) (3,101 ) The components of earnings (loss) from continuing operations before income taxes are shown below: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Canada (10,797 ) (14,700 ) (11,295 ) U.S. 3,945 (34,521 ) (5,548 ) Other (658 ) (821 ) 662 Loss from continuing operations before income taxes (7,510 ) (50,042 ) (16,181 ) The components of income tax expense (benefit) are shown below: January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Current income tax expense (benefit): Canada (9 ) (154 ) (1,023 ) U.S. (75 ) (14,148 ) (3,424 ) Other (359 ) 589 532 (443 ) (13,713 ) (3,915 ) Deferred income tax expense (benefit): Canada 299 (291 ) 33 U.S. (3,067 ) 10,442 731 Other (155 ) 822 50 (2,923 ) 10,973 814 Income tax benefit (3,366 ) (2,740 ) (3,101 )
Schedule of deferred tax assets and liabilities [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Differences in property, plant and equipment and intangible assets (54,761 ) (55,105 ) Capital and non-capital losses 21,540 14,388 Interest expense limitation (163j) 10,521 11,069 Tax benefit of scientific research expenditures 2,744 2,699 Inventory basis differences 1,148 1,303 Other accrued reserves 1,590 4,522 (17,218 ) (21,124 ) Less: valuation allowance 5,267 4,284 Deferred income tax liability (22,485 ) (25,408 )
Schedule of deferred tax assets and liabilities by geographic segment [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Canada (325 ) (26 ) U.S. (22,083 ) (25,150 ) Other (77 ) (232 ) Deferred income tax liability (22,485 ) (25,408 )
Schedule of deferred income tax valuation allowance [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Balance, beginning of year 4,284 6,219 Increase (decrease) in valuation allowance 983 (1,935 ) Balance, end of year 5,267 4,284

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Jan. 01, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 Basic Earnings (Loss) Per Share Numerator for basic earnings (loss) per share: Loss from continuing operations $ (4,144 ) $ (47,302 ) $ (13,080 ) Less: dividends and accretion on Series A Preferred Stock (1,212 ) (8,319 ) (8,022 ) Less: dividends and accretion on Series B-1 Preferred Stock (2,985 ) (2,009 ) - Loss from continuing operations attributable to common shareholders (8,341 ) (57,630 ) (21,102 ) Earnings from discontinued operations - 124,820 12,322 Earnings (loss) attributable to common shareholders $ (8,341 ) $ 67,190 $ (8,780 ) Denominator for basic earnings (loss) per share: Basic weighted-average number of shares outstanding 104,098 89,234 87,787 Basic earnings (loss) per share: From continuing operations $ (0.08 ) $ (0.65 ) $ (0.24 ) From discontinued operations - 1.40 0.14 Basic earnings (loss) per share $ (0.08 ) $ 0.75 $ (0.10 ) Diluted Earnings (Loss) Per Share Numerator for diluted earnings (loss) per share: Loss from continuing operations $ (4,144 ) $ (47,302 ) $ (13,080 ) Less: dividends and accretion on Series A Preferred Stock (1,212 ) (8,319 ) (8,022 ) Less: dividends and accretion on Series B-1 Preferred Stock (2,985 ) (2,009 ) - Loss from continuing operations attributable to common shareholders (8,341 ) (57,630 ) (21,102 ) Earnings from discontinued operations - 124,820 12,322 Earnings (loss) attributable to common shareholders $ (8,341 ) $ 67,190 $ (8,780 ) Denominator for diluted earnings (loss) per share: Basic weighted-average number of shares outstanding 104,098 89,234 87,787 Dilutive effect of the following: Stock options and restricted stock units (1) - - - Series B-1 Preferred Stock (2) - - - Series A Preferred Stock (3) - - - Diluted weighted-average number of shares outstanding 104,098 89,234 87,787 Diluted earnings (loss) per share: From continuing operations $ (0.08 ) $ (0.65 ) $ (0.24 ) From discontinued operations - 1.40 0.14 Diluted earnings (loss) per share $ (0.08 ) $ 0.75 $ (0.10 )

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	12 Months Ended
	Jan. 01, 2022
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Changes in Operating Assets and Liabilities, Net of Businesses Sold Accounts receivable (11,978 ) (746 ) 4,013 Inventories (72,395 ) 6,133 7,097 Accounts payable and accrued liabilities 16,195 11,322 (5,861 ) Other operating assets and liabilities 4,423 422 (4,518 ) (63,755 ) 17,131 731 Non-Cash Investing and Financing Activities Change in additions to property, plant and equipment included in accounts payable and accrued liabilities 3,482 2,043 (2,886 ) Change in accrued dividends on preferred stock (1,769 ) 679 - Dividends paid in kind on preferred stock (see note 15) - 3,881 - Change in accrued transaction costs related to the divestiture of Tradin Organic (see note 13) (1) (13,380 ) 13,380 - Change in accrued debt issuance costs (see note 13) (1,690 ) 1,690 - Cash Paid Interest 6,610 30,740 30,399 Income taxes 3,632 935 410

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Jan. 01, 2022
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Segment revenues from external customers Plant-Based Foods and Beverages 470,754 415,164 361,398 Fruit-Based Foods and Beverages 341,870 374,049 349,852 Global Ingredients - - 10,346 Total revenues from external customers 812,624 789,213 721,596 Segment operating income (loss) Plant-Based Foods and Beverages 36,981 50,780 29,476 Fruit-Based Foods and Beverages (9,320 ) (7,321 ) (26,873 ) Global Ingredients - - (187 ) Corporate Services (17,512 ) (31,151 ) (26,471 ) Total segment operating income 10,149 12,308 (24,055 ) Other income (expense), net (see note 18) (8,890 ) (23,393 ) 40,639 Interest expense, net (see note 14) (8,769 ) (30,042 ) (32,765 ) Loss on retirement of debt (see note 14) - (8,915 ) - Loss from continuing operations before income taxes (7,510 ) (50,042 ) (16,181 )
Schedule of Assets from Segment to Consolidated [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Segment Assets Plant-Based Foods and Beverages 301,065 191,580 Fruit-Based Foods and Beverages 368,976 329,151 Corporate Services 85,078 64,884 Total assets 755,119 585,615
Reconciliation of Other Significant Reconciling Items from Segments to Consolidated [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Segment Capital Expenditures Plant-Based Foods and Beverages 38,760 11,323 15,289 Fruit-Based Foods and Beverages 5,926 10,378 9,689 Global Ingredients - - 92 Corporate Services 13,611 3,053 3,317 Total capital expenditures 58,297 24,754 28,387 Segment Depreciation and Amortization Plant-Based Foods and Beverages 14,942 9,457 7,799 Fruit-Based Foods and Beverages 14,918 16,304 16,702 Global Ingredients - - 129 Corporate Services 4,781 4,547 4,636 Total depreciation and amortization 34,641 30,308 29,266
Schedule of Segment Revenue from External Customers by Segment [Table Text Block]	January 1, 2022 January 2, 2021 December 28, 2019 $ $ $ Revenues from External Customers U.S. 772,333 752,000 691,838 Canada 14,067 12,481 9,418 Other 26,224 24,732 20,340 Total revenues from external customers 812,624 789,213 721,596
Schedule of Segment Long-lived Assets by Geographic Areas [Table Text Block]	January 1, 2022 January 2, 2021 $ $ Long-Lived Assets U.S. 203,318 144,555 Mexico 14,124 11,511 Canada 2,095 1,982 Total long-lived assets 219,537 158,048

Significant Accounting Polici_4

Significant Accounting Policies (Narrative) (Details)	12 Months Ended
	Jan. 01, 2022
Significant Accounting Policies [Line Items]
Operating cycle	The fiscal year of the Company consists of a 52- or 53-week period ending on the Saturday closest to December 31. Fiscal year 2021 was a 52-week period ending on January 1, 2022, fiscal year 2020 was a 53-week period ending on January 2, 2021, and fiscal year 2019 was a 52-week period ending on December 28, 2019. Fiscal year 2022 will be a 52-week period ending on December 31, 2022, with quarterly periods ending on April 2, 2022, July 2, 2022, and October 1, 2022.
Description of trade receivable balance	As at January 1, 2022, three long-term customers represented approximately 14%, 13% and 12%, respectively, of the Company's consolidated trade receivables balance
Description of threshold limit of income tax positions	for those tax positions that meet the more-likely-than-not recognition threshold, the Company recognizes the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the related tax authority
Customer relationships [Member] | Minimum [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	10 years
Customer relationships [Member] | Maximum [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	25 years
Brand names [Member]
Significant Accounting Policies [Line Items]
Finite-Lived Intangible Asset, Useful Life	15 years

Significant Accounting Polici_5

Significant Accounting Policies (Schedule Of Useful Life for Property Plant and Equipment) (Details)	12 Months Ended
	Jan. 01, 2022
Buildings [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	20 years
Buildings [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	40 years
Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years
Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	20 years
Enterprise software [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Enterprise software [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	5 years
Office furniture and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Office furniture and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	7 years
Vehicles [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	3 years
Vehicles [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property plant and equipment useful life	7 years

Revenue (Disaggregation Of Reve

Revenue (Disaggregation Of Revenue) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	$ 812,624	$ 789,213	$ 721,596
Plant-Based Foods and Beverages [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	470,754	415,164	361,398
Plant-Based Foods and Beverages [Member] | Beverages and broths [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	376,525	332,390	286,381
Plant-Based Foods and Beverages [Member] | Plant-based ingredients [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	31,135	28,156	22,944
Plant-Based Foods and Beverages [Member] | Sunflower and roasted snacks [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	63,094	54,618	52,073
Fruit-Based Foods and Beverages [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	341,870	374,049	349,852
Fruit-Based Foods and Beverages [Member] | Frozen fruit and fruit-based ingredients [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	279,128	325,102	306,060
Fruit-Based Foods and Beverages [Member] | Fruit snacks [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	62,742	48,947	43,792
Global Ingredients [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	0	0	10,346
Global Ingredients [Member] | Soy And Corn [Member]
Disaggregation of Revenue [Line Items]
Segment revenues from external customers	$ 0	$ 0	$ 10,346

Acquisition of Dream and West_2

Acquisition of Dream and WestSoy Brands (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Apr. 15, 2021	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Business Acquisition [Line Items]
Acquired inventories		$ 72,395	$ (6,133)	$ (7,097)
Acquired brand name intangible assets		$ 25,073	$ 0	$ 0
Dream and WestSoy plant-based beverage brands [Member] | The Hain Celestial Group, Inc. [Member]
Business Acquisition [Line Items]
Cash purchase price	$ 33,000
Final purchase price	31,700
Direct transaction costs	400
Acquired inventories	6,600
Acquired brand name intangible assets	$ 25,100
Intangible assets amortized over estimated useful life	15 years

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details) $ in Thousands, € in Millions	12 Months Ended
	Jan. 01, 2022USD ($)	Jan. 02, 2021USD ($)	Dec. 28, 2019USD ($)	Dec. 30, 2020EUR (€)	Dec. 30, 2020USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on foreign currency forward contract	$ 0	$ 12,658	$ 0
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash consideration				€ 305.1	$ 373,700
Pre-tax gain on sale		111,818	$ 0
Dutch Sub Facility Global Credit Facility [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Repayment of outstanding borrowings		72,000
Senior Secured Second Lien Notes [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Early repayment of subordinated debt		$ 233,300
Debt instrument, interest rate		9.50%
Accrued interest and premium paid on redemption		$ 9,800
Global Credit Facility [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Repayment of outstanding borrowings		$ 60,000

Discontinued Operations - (Sche

Discontinued Operations - (Schedule of disposal groups including discontinued operations, income statement, balance sheet and additional disclosures) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Earnings from discontinued operations	$ 0	$ 124,820	$ 12,322
Tradin Organic [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues		503,036	468,426
Cost of goods sold		441,277	418,676
Selling, general and administrative expenses		26,953	27,737
Intangible asset amortization		1,451	1,859
Other expense (income), net		(782)	591
Foreign exchange loss (gain)		3,142	(1,147)
Interest Expense		2,409	1,912
Earnings before gain of sale		28,586	18,798
Pre-tax gain on sale		111,818	0
Earnings from discontinued operations before income taxes		140,404	18,798
Income tax expense		15,885	6,322
Earnings (loss) attributable to non-controlling interests		(301)	154
Earnings from discontinued operations		$ 124,820	$ 12,322

Sale of Soy and Corn Business (

Sale of Soy and Corn Business (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Feb. 22, 2019	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Net proceeds used to repay outstanding indebtedness		$ 0	$ 0	$ 63,324
Pipeline Foods, LLC [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$ 10,300			$ 44,000
Earnings (loss) before income taxes	$ (200)

Derivative Financial Instrume_2

Derivative Financial Instruments (Narrative) (Details) - Not designated as hedging instruments [Member] - Foreign currency put and call option contracts (a zero-cost collar) [Member] $ in Millions	12 Months Ended
	Jan. 01, 2022USD ($)	Jan. 02, 2021USD ($)
Derivative [Line Items]
Derivative, notional amount	$ 11.8
Collar ceiling rate of Mexican pesos to US dollar	24
Floor rate of Mexican pesos to US dollar	21.14
Foreign exchange gain (loss)	$ (0.3)	$ 2.2

Accounts Receivable (Schedule o

Accounts Receivable (Schedule of trade receivables) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Receivables [Abstract]
Trade receivables	$ 85,591	$ 73,981
Allowance for doubtful accounts	(889)	(1,257)
Total	$ 84,702	$ 72,724

Accounts Receivable (Schedule_2

Accounts Receivable (Schedule of allowance for doubtful accounts) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Receivables [Abstract]
Balance, beginning of year	$ 1,257	$ 630
Net addition (reduction) to provision	(368)	627
Balance, end of year	$ 889	$ 1,257

Inventories (Schedule of invent

Inventories (Schedule of inventory, current) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Inventory Disclosure [Abstract]
Raw materials and work-in-process	$ 143,381	$ 78,210
Finished goods	81,546	75,280
Inventory reserves	(4,784)	(5,742)	$ (8,135)
Total Inventory, Net	$ 220,143	$ 147,748

Inventories (Schedule of inve_2

Inventories (Schedule of inventory reserve) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Inventories [Roll Forward]
Balance, beginning of year	$ 5,742	$ 8,135
Additions to reserve during the year	5,854	3,081
Reserves applied and inventories written off during the year	(6,812)	(5,474)
Balance, end of year	$ 4,784	$ 5,742

Property, Plant and Equipment_2

Property, Plant and Equipment (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Property, Plant and Equipment [Line Items]
Construction in process assets	$ 48.7	$ 23.7
Inventory, parts and components, net of reserves	7	5.6
Depreciation	$ 24.7	$ 21.4	$ 20.2

Property, Plant and Equipment_3

Property, Plant and Equipment (Schedule of property, plant and equipment) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Property, Plant and Equipment [Line Items]
Cost	$ 365,451	$ 308,506
Accumulated depreciation	145,914	150,458
Net book value	219,537	158,048
Land [Member]
Property, Plant and Equipment [Line Items]
Cost	6,963	7,009
Accumulated depreciation	0	0
Net book value	6,963	7,009
Building [Member]
Property, Plant and Equipment [Line Items]
Cost	94,935	75,308
Accumulated depreciation	22,510	23,587
Net book value	72,425	51,721
Machinery and equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	236,779	191,831
Accumulated depreciation	107,319	103,092
Net book value	129,460	88,739
Enterprise software [Member]
Property, Plant and Equipment [Line Items]
Cost	19,900	25,250
Accumulated depreciation	11,740	16,009
Net book value	8,160	9,241
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Cost	5,429	7,258
Accumulated depreciation	3,130	6,157
Net book value	2,299	1,101
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Cost	1,445	1,850
Accumulated depreciation	1,215	1,613
Net book value	$ 230	$ 237

Leases (Narrative) (Details)

Leases (Narrative) (Details)	12 Months Ended
	Jan. 01, 2022
Operating Leased Assets [Line Items]
Right-of-Use Asset for which lease had not commenced	For the year ended January 1, 2022, net cash received for amounts included in financing cash flows from finance leases reflected cash advances of $13.6 million received by the Company under finance leases that have not commenced that relate to the construction of right-of-use assets controlled by the Company, partially offset by cash repayments of $8.8 million made by the Company related to finance leases that have commenced.
Minimum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Term of Contract	1 year
Maximum [Member]
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Term of Contract	12 years
Real estate operating leases
Operating Leased Assets [Line Items]
Lessee, Operating Lease, Renewal Term	15 years

Lease, Cost (Details)

Lease, Cost (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Lease Costs
Operating lease cost	$ 13,806	$ 16,647	$ 18,192
Finance lease cost, Depreciation of right-of-use assets	5,922	2,647	1,439
Finance lease cost, Interest on lease liabilities	2,752	675	267
Sublease income	(281)	(504)	(476)
Net lease cost	$ 22,199	$ 19,465	$ 19,422

Leases, Balance Sheet Classific

Leases, Balance Sheet Classification (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Operating leases
Operating lease right-of-use assets	$ 47,245	$ 35,172
Current portion of operating lease liabilities	12,203	12,750
Operating lease liabilities	39,028	24,582
Total operating lease liabilities	51,231	37,332
Finance leases
Property, plant and equipment, gross	365,451	308,506
Accumulated depreciation	(145,914)	(150,458)
Property, plant and equipment, net	219,537	158,048
Current portion of long-term debt	9,760	3,146
Long-term debt	43,034	15,667
Total finance lease liabilities	52,794	18,813
Finance Leases [Member]
Finance leases
Property, plant and equipment, gross	66,060	24,534
Accumulated depreciation	(10,348)	(5,787)
Property, plant and equipment, net	$ 55,712	$ 18,747

Leases, Cash Flow Information (

Leases, Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Cash Flow Information
Operating cash flows from operating leases	$ 13,391	$ 16,741	$ 18,405
Operating cash flows from finance leases	2,752	675	267
Financing cash flows from finance leases	(4,828)	2,587	1,123
Right-of-use assets obtained in exchange for lease liabilities:
Operating leases	29,015	5,962	2,760
Finance Leases	29,906	5,179	14,549
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Impairment of operating lease right-of-use assets	0	1,538	0
Operating Leases [Member]
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Gain (Loss) on Termination of Lease	(2,261)	(23,667)	0
Finance Leases [Member]
Right-of-use assets and liabilities reduced through lease terminations or modifications:
Gain (Loss) on Termination of Lease	$ (686)	$ 0	$ 0

Leases, Other Information (Deta

Leases, Other Information (Details)	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Leases [Abstract]
Weighted-average remaining lease term (years), Operating leases	7 years 4 months 24 days	3 years 4 months 24 days	6 years 1 month 6 days
Weighted-average remaining lease term (years), Finance leases	4 years 3 months 18 days	5 years 3 months 18 days	5 years 10 months 24 days
Weighted-average discount rate, Operating leases	5.00%	6.60%	9.20%
Weighted-average discount rate, Finance leases	6.60%	5.40%	4.50%

Leases - Lessee, Operating Leas

Leases - Lessee, Operating Lease, Liability, Maturity (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Operating leases
2022	$ 10,728
2023	10,184
2024	8,264
2025	6,245
2026	5,236
Thereafter	21,638
Total lease payments	62,295
Less: imputed interest	(11,064)
Total operating lease liabilities	51,231	$ 37,332
Finance leases
2022	11,965
2023	14,035
2024	13,971
2025	14,665
2026	6,824
Thereafter	0
Total lease payments	61,460
Less: imputed interest	(8,666)
Total lease liabilities	$ 52,794	$ 18,813

Intangible assets (Major Compon

Intangible assets (Major Components) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Finite-Lived Intangible Assets [Line Items]
Cost	$ 216,399	$ 191,326
Accumulated amortization	67,959	58,009
Net book value	148,440	133,317
Customer relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	189,407	189,407
Accumulated amortization	64,867	56,090
Net book value	124,540	133,317
Brand names [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	25,073	0
Accumulated amortization	1,173	0
Net book value	23,900	0
Other [Member]
Finite-Lived Intangible Assets [Line Items]
Cost	1,919	1,919
Accumulated amortization	1,919	1,919
Net book value	$ 0	$ 0

Intangible assets (Future Amort

Intangible assets (Future Amortization) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2022	$ 10,448
2023	10,448
2024	10,448
2025	10,448
2026	10,138
Thereafter	96,510
Total	$ 148,440	$ 133,317

Goodwill (Narrative) (Details)

Goodwill (Narrative) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Goodwill [Line Items]
Goodwill	$ 3,998	$ 3,998
Goodwill, accumulated impairment loss	$ 213,800

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Payables and Accruals [Abstract]
Accounts payable	$ 105,386	$ 73,204
Payroll and benefits	8,861	25,423
Accrued interest	846	41
Dividends payable on preferred stock	609	2,378
Accrued costs to sell related to Tradin Organic divestiture	0	13,380
Accrued debt issuance costs	0	1,690
Other accruals	5,728	2,476
Accounts Payable and Accrued Liabilities	$ 121,430	$ 118,592

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Apr. 15, 2021	Dec. 31, 2020	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Debt Instrument [Line Items]
Loss on the retirement of note			$ 0	$ 8,915	$ 0
Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Amendment Description			On February 25, 2022, the Company entered into a third amendment to the Credit Agreement to, among other things: (i) provide for the replacement of LIBOR with the Secured Overnight Financing Rate ("SOFR"); (ii) extend the maturity date of the Tranche B Subfacility by one year to April 15, 2024, with amortization payments on the aggregate principal amount of the Tranche B Subfacility of $2.5 million, payable at the end of each fiscal quarter, commencing with the fiscal quarter ending March 31, 2023, with the remaining amount payable at the maturity thereof; (iii) extend the period that the Term Loan Facility can be used for borrowings from June 30, 2022 to March 31, 2023; (iv) extend the repayment start date of the Term Loan Facility from July 31, 2022 to March 31, 2023, with monthly repayments equal to 1/84th of the then-outstanding principal amount of the Term Loan Facility; (v) amend the maximum senior funded leverage ratio with respect to the Term Loan Facility to 5.50 to 1.00 from the fiscal quarter ending March 31, 2022 to the fiscal quarter ending September 30, 2022, 5.00 to 1.00 for the fiscal quarter ending December 31, 2022, 4.75 to 1.00 from the fiscal quarter ending March 31, 2023 to the fiscal quarter ending June 30, 2023, 4.25 to 1.00 from the fiscal quarter ending September 30, 2023 to the fiscal quarter ending December 31, 2023, 3.50 to 1.00 from the fiscal quarter ending March 31, 2024 to the fiscal quarter ending June 30, 2024, and 3.25 to 1.00 from the fiscal quarter ending September 30, 2024 until the Term Loan Facility termination date; (vi) increase certain advance rates and add new classes of eligible assets to the Tranche A Subfacility borrowing base calculation; and (vii) delay by one year to January 1, 2023, a 0.25% margin reduction when the Company's total leverage ratio is less than a specific threshold.
Line of Credit Facility, Interest Rate Description			For the year ended January 1, 2022, the weighted-average interest rate on all outstanding borrowings under the Revolving Credit Facilities was 2.36%. Borrowings under the Asset-Based Credit Facilities bear interest based on various reference rates plus an applicable margin, which are set quarterly based on average borrowing availability for the preceding fiscal quarter. Effective from the date of the third amendment to the Credit Agreement, the applicable margin for loans under the Tranche A Subfacility range from 0.50% to 1.00% for base rate loans and from 1.50% to 2.00% for SOFR loans, bankers' acceptance equivalent loans and European base rate loans. The applicable margin on loans under the Tranche B Subfacility are the applicable margin for the Tranche A Subfacility plus 1.00%. With respect to loans under the Term Loan Facility, the applicable margin ranges from 1.25% to 1.75% for base rate loans and from 2.25% to 2.75% for SOFR loans. In addition, a credit spread adjustment of 0.10% applies to all SOFR loans. In addition to paying interest on outstanding principal under the Asset-Based Credit Facilities, the Company is required to pay commitment fees quarterly, in arrears, equal to (i) 0.25% of the average daily undrawn portion of the Revolving Credit Facilities and (ii) 0.375% of the undrawn portion of the Term Loan Facility.
Term Loan Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 75,000
Debt Instrument, Term		5 years
Senior Secured Second Lien Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage				9.50%
Debt Instrument, Redemption Price, Percentage				102.375%
Debt redeemed and retired, amount				$ 223,500
Tranche A Subfacility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Covenant Terms			The Asset-Based Credit Facilities are subject to a number of covenants that, among other things, restrict the Company's ability to create liens on assets; sell assets and enter in sale and leaseback transactions; pay dividends, prepay junior lien and unsecured indebtedness and make other restricted payments; incur additional indebtedness, including finance lease obligations in excess of $150 million, and make guarantees; make investments, loans or advances, including acquisitions; and engage in mergers or consolidations. In addition, the Company and its restricted subsidiaries are required to maintain a minimum fixed charge coverage ratio of 1.0 to 1.0 if excess availability is less than the greater of (i) $15.0 million or (ii) 10% of the lesser of (x) the aggregate commitments under the Revolving Credit Facilities and (y) the aggregate borrowing base, as well as the maximum senior funded leverage ratio covenant (as amended above) with respect to the Term Loan Facility. As at January 1, 2022, the Company was in compliance with all covenants of the Credit Agreement.
Line of Credit Facility, Remaining Borrowing Capacity			$ 230,000
Tranche A Subfacility [Member] | Line of credit facility, maximum borrowing capacity [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		$ 250,000
Debt Instrument, Term		5 years
Tranche B Subfacility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 20,000
Debt Instrument, Term	2 years

Long-Term Debt (Schedule of Lin

Long-Term Debt (Schedule of Line of Credit Facilities) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Line of Credit Facility [Line Items]
Total asset-based credit facilities	$ 164,899	$ 47,277
Finance lease liabilities	52,794	18,813
Other	6,910	3,633
Total debt	224,603	69,723
Less: current portion	9,760	3,478
Long-term Debt, Excluding Current Maturities, Total	214,843	66,245
Revolving Credit Facility [Member]
Line of Credit Facility [Line Items]
Total asset-based credit facilities	153,293	47,277
Term loan facility [Member]
Line of Credit Facility [Line Items]
Total asset-based credit facilities	$ 11,606	$ 0

Long-Term Debt (Schedule of Mat

Long-Term Debt (Schedule of Maturities of Long-term Debt) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Debt Disclosure [Abstract]
2022	$ 11,965
2023	15,417
2024	15,629
2025	176,524
2026	10,711
Thereafter	3,023
Total gross repayments	233,269
Less: imputed interest	(8,666)
Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year	$ 224,603	$ 69,723

Long-Term Debt (Schedule of Int

Long-Term Debt (Schedule of Interest Expense and Interest Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Debt Disclosure [Abstract]
Interest expense	$ 7,685	$ 26,816	$ 30,950
Amortization of debt issuance costs	1,353	4,078	2,721
Interest income	(269)	(852)	(906)
Interest expense, net	$ 8,769	$ 30,042	$ 32,765

Preferred Stock (Narrative) (De

Preferred Stock (Narrative) (Details) - USD ($)	2 Months Ended	12 Months Ended
	Feb. 22, 2021	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019	Apr. 24, 2020	Oct. 07, 2016
Temporary Equity [Line Items]
Dividends, Preferred Stock, Paid-in-kind		$ 0	$ 3,881,000	$ 0
Preferred stock accretion to redemption value		720,000	1,692,000	$ 1,222,000
Series A Preferred Stock [Member] | Oaktree Organics, L.P. and Oaktree Huntington Investment Fund II, L.P.
Temporary Equity [Line Items]
Number of share issue for conversion preferred stock	12,633,427
Preferred Stock, Shares Issued						85,000
Preferred Stock, Value, Issued	$ 87,500					$ 85,000,000
Preferred stock, conversion price	$ 7
Preferred Stock, Dividend Rate, Percentage	8.00%
Preferred Stock Issuance Costs	$ 300,000					$ 6,000,000
Remaining unamortized issuance costs		900,000
Payment of cash dividends	1,000,000	$ 1,800,000
Dividends, Preferred Stock, Paid-in-kind	3,400,000
Conversion of Stock, Description		On February 22, 2021 (the "Exchange Date"), Oaktree exchanged all of their shares of Series A Preferred Stock for 12,633,427 shares of common stock of the Company ("Common Shares") at an exchange price of $7.00. Prior to the exchange, the Series A Preferred Stock provided for a cumulative dividend of 8.0% per year. On the Exchange Date, the Company paid cash dividends of $1.0 million on the Series A Preferred Stock for the period January 1, 2021 to February 22, 2021. In addition, in the first quarter of 2021, the Company paid cash dividends of $1.8 million on Series A Preferred Stock related to the fourth quarter of 2020. Subsequent to the Exchange Date, the Company is no longer required to pay dividends on the Series A Preferred Stock.
Preferred Stock, Liquidation Preference, Value	$ 85,000,000
Stock Redeemed or Called During Period, Shares	12,633,427
Series B-1 Preferred Stock [Member] | Stock issued to each recipient [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued					15,000
Series B-1 Preferred Stock [Member] | Oaktree and Engaged [Member]
Temporary Equity [Line Items]
Preferred Stock, Shares Issued					30,000
Preferred Stock, Value, Issued					$ 30,000,000
Preferred Stock Issuance Costs					$ 3,200,000
Payment of cash dividends		$ 600,000
Dividends, Preferred Stock, Paid-in-kind		$ 400,000
Preferred Stock, Liquidation Preference Per Share		$ 1,015			$ 1,000
Preferred Stock, Liquidation Preference, Value		$ 30,400,000
Preferred Stock, Dividend Payment Terms		Cumulative preferred dividends accrue daily on the Series B-1 Preferred Stock at an annualized rate of 8.0% of the Series B-1 Liquidation Preference prior to September 30, 2029, and 10.0% of the liquidation preference thereafter (subject to an increase of 1.0% per quarter, up to a maximum rate of 5.0% per quarter on the occurrence of certain events of non-compliance).
Accrued Unpaid Dividends		$ 600,000
Preferred stock accretion to redemption value		$ 500,000	$ 300,000
Preferred Stock, Convertible, Terms		At any time, the Series B-1 Preferred Stock may be exchanged, in whole or in part, into the number of Common Shares equal to, per share of Series B-1 Preferred Stock, the quotient of the Series B Liquidation Preference divided by $2.50 (such price, the "Series B-1 Exchange Price" and such quotient, the "Series B-1 Exchange Rate").
Convertible Preferred Stock, Settlement Terms		SunOpta Foods may cause the holders of the Series B-1 Preferred Stock to exchange all of their shares of Series B-1 Preferred Stock into a number of Common Shares equal to the number of shares of Series B-1 Preferred Stock outstanding multiplied by the Series B-1 Exchange Rate if (i) fewer than 10% of the shares of Series B-1 Preferred Stock issued on April 24, 2020 remain outstanding, or (ii) on or after April 24, 2023, the average volume-weighted average price of the Common Shares during the then preceding 20 trading day period is greater than 200% of the Series B-1 Exchange Price then in effect.
Maximum holder beneficial ownership		19.99%
Preferred stock, convertible shares issuable		12,178,667
Preferred stock exchange, description of exchange price		The Series B-1 Exchange Price is subject to certain anti-dilution adjustments, including a weighted-average adjustment for issuances of Common Shares below the Series B-1 Exchange Price, provided that the Series B-1 Exchange Price may not be lower than $2.00 (subject to adjustment in certain circumstances).
Series B Preferred Stock [Member] | Oaktree and Engaged [Member]
Temporary Equity [Line Items]
Preferred Stock, Convertible, Terms		Oaktree and Engaged are entitled to vote the Series B-1 Preferred Stock with the Common Shares on an as-exchanged basis, subject to a permanent 19.99% voting cap. As a result of the voting cap, each of Oaktree and Engaged will only be able to vote its Series B-1 Preferred Stock to the extent that, when taken together with any other voting securities each investor controls, such votes do not exceed 19.99% of the votes eligible to be cast by all security holders of the Company. On April 24, 2020, the Company designated Special Shares, Series 2 to serve as the mechanism for attaching exchanged voting rights to the Series B-1 Preferred Stock. The Special Shares, Series 2 entitle the holder thereof to one vote per Special Share, Series 2 on all matters submitted to a vote of the holders of Common Shares, voting together as a single class, subject to certain exceptions. The Special Shares, Series 2 are not transferrable and the voting rights associated with the Special Shares, Series 2 will terminate upon the transfer of the shares of Series B-1 Preferred Stock to a third party, other than an affiliate of Oaktree or Engaged, as applicable. As at January 1, 2022, 6,089,333 Special Shares, Series 2 were issued to Engaged, equal to the number of Common Shares issuable to Engaged on the exchange of all of the shares of Series B-1 Preferred Stock held by it, and no Special Shares, Series 2 were issued to Oaktree, as Oaktree was subject to the Series B-1 Exchange Cap.
Special Voting Shares, issued and outstanding		6,089,333

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details)	Sep. 03, 2019USD ($)$ / sharesshares	Apr. 01, 2019USD ($)$ / sharesshares	Jan. 01, 2022USD ($)$ / shares$ / sharesshares	Jan. 01, 2022USD ($)$ / sharesshares	Jan. 02, 2021USD ($)$ / sharesshares	Dec. 28, 2019USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of previously recognized stock-based compensation expense related to forfeited awards | $					$ 900,000	$ 4,100,000
Intrinsic value of stock options exercised | $				$ 5,100,000
Employee share purchase plan | $				$ 583,000	$ 462,000	$ 475,000
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted				142,499
Exercise price of stock option to purchase one common share | $ / shares				$ 14.77
Weighted-average grant-date fair value of options | $ / shares				$ 8.10	$ 2.52	$ 1.70
Compensation costs related to awards not yet recognized | $			$ 1,300,000	$ 1,300,000
Vesting period	3 years			2 years
Expiration period	10 years
Trading price | $ / shares			$ 14.77	$ 14.77	$ 4.64	$ 3.57
Expected life (in years)				6 years	6 years	5 years 9 months 18 days
Employee share purchase plan | $				$ 600,000	$ 500,000	$ 500,000
Employee stock purchase plan (in shares)				66,834	113,581	185,415
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding			634,082	634,082
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted				666,332
Weighted-average grant-date fair value of options | $ / shares	$ 0.79	$ 1.77		$ 13.90	$ 3.54	$ 3.42
Compensation costs related to awards not yet recognized | $			$ 400,000	$ 400,000
Vesting period				1 year 6 months
Compensation expense not recognized | $			9,000,000	$ 9,000,000
Intrinsic value | $			37,300,000	$ 37,300,000
Trading price | $ / shares	2.38	3.36
Performance Shares [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting PSU's				0.00%
Performance Shares [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting PSU's				200.00%
Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted				245,848
Weighted-average grant-date fair value of options | $ / shares	1.18	1.68		$ 13.32	$ 3.20	$ 3.33
Compensation costs related to awards not yet recognized | $			2,600,000	$ 2,600,000
Vesting period				2 years
Intrinsic value | $			$ 3,800,000	$ 3,800,000
Trading price | $ / shares	$ 2.45	$ 3.46
Percentage of vesting PSU's				100.00%
Total Shareholder Return Performance Shares "(TSR PSU") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted				74,428
Weighted-average grant-date fair value of options | $ / shares			$ 23.40
Vesting period				2 years 3 months 18 days
Intrinsic value | $			$ 1,300,000	$ 1,300,000
CEO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate grant-date fair value of stock awards | $			8,000,000	8,000,000
Compensation costs related to awards not yet recognized | $			$ 1,100,000	$ 1,100,000
Vesting period				9 months 18 days
CEO [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted		960,061
Exercise price of stock option to purchase one common share | $ / shares		$ 3.36
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				0
Trading price | $ / shares			$ 3.36	$ 3.36
Expected life (in years)				6 years 6 months
CEO [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of consecutive trading days		20 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		1,785,714
Intrinsic value | $			$ 11,500,000	$ 11,500,000
Trading price | $ / shares			$ 3.36	$ 3.36
Expected life (in years)				1 year 9 months 18 days
CEO [Member] | Performance Shares [Member] | Fiscal Years 2019 Through 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		892,857
CEO [Member] | Performance Shares [Member] | Vest upon the Company achieving annual adjusted EBITDA of $43 million
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		297,619
Original EBITDA threshold | $		$ 43,000,000
CEO [Member] | Performance Shares [Member] | Vest upon the Company achieving annual adjusted EBITDA of $65 million
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		297,619
Original EBITDA threshold | $		$ 65,000,000
CEO [Member] | Performance Shares [Member] | Vest upon the Company achieving annual adjusted EBITDA of $87 million
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		297,619
Original EBITDA threshold | $		$ 87,000,000
CEO [Member] | Performance Shares [Member] | Vest upon Common Shares achieving certain volume-weighted average trading prices [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		892,857
CEO [Member] | Performance Shares [Member] | Vest upon achieving a trading price of $5.00 per share [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of consecutive trading days		20 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		297,619
Trading price | $ / shares		$ 5
CEO [Member] | Performance Shares [Member] | Vest upon achieving a trading price of $9.00 per share [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		297,619
Trading price | $ / shares		$ 9
CEO [Member] | Performance Shares [Member] | Vest upon achieving a trading price of $14.00 per share [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		297,619
Trading price | $ / shares		$ 14
CEO [Member] | Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		512,619
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				170,873
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period		215,000
CFO [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate grant-date fair value of stock awards | $			$ 2,100,000	$ 2,100,000
Compensation costs related to awards not yet recognized | $			$ 700,000	$ 700,000
Vesting period				1 year 4 months 24 days
CFO [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Granted	262,182
Exercise price of stock option to purchase one common share | $ / shares	$ 2.38
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period				0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				0
Trading price | $ / shares			$ 2.38	$ 2.38
Expected life (in years)				6 years 6 months
CFO [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	346,638
Intrinsic value | $			$ 2,800,000	$ 2,800,000
Trading price | $ / shares			$ 2.38	$ 2.38
Expected life (in years)				2 years 1 month 6 days
CFO [Member] | Performance Shares [Member] | Fiscal Years 2019 Through 2022 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	173,319
CFO [Member] | Performance Shares [Member] | Vest upon the Company achieving annual adjusted EBITDA of $43 million
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	57,773
Original EBITDA threshold | $	$ 43,000,000
CFO [Member] | Performance Shares [Member] | Vest upon the Company achieving annual adjusted EBITDA of $65 million
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	57,773
Original EBITDA threshold | $	$ 65,000,000
CFO [Member] | Performance Shares [Member] | Vest upon the Company achieving annual adjusted EBITDA of $87 million
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	57,773
Original EBITDA threshold | $	$ 87,000,000
CFO [Member] | Performance Shares [Member] | Vest upon achieving a trading price of $5.00 per share [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of consecutive trading days	20 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	57,773
Trading price | $ / shares	$ 5
CFO [Member] | Performance Shares [Member] | Vest upon achieving a trading price of $9.00 per share [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	57,773
Trading price | $ / shares	$ 9
CFO [Member] | Performance Shares [Member] | Vest upon achieving a trading price of $14.00 per share [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	57,773
Trading price | $ / shares	$ 14
CFO [Member] | Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	327,819			29,090
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period				109,273
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Issued In Period	154,500
Grant-date fair value of additional RSUs | $				$ 15.49
2013 Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of securities issuance under the Plan			4,373,448	4,373,448
2021 Long-Term Incentive Plan [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted-average grant-date fair value of options | $ / shares				$ 23.40

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of stock-based compensation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 9,100	$ 12,216	$ 7,485
Selling, general and administrative expenses [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	9,100	12,570	10,471
Other income [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	0	(894)	(4,131)
Earnings from discontinued operations [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 0	$ 540	$ 1,145

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of stock option activity (Details) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 01, 2022USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options Outstanding, Exercisable, end of year | shares	665,988
Stock options Exercisable, Weighted-average exercise price end of year | $ / shares	$ 7.46
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, Outstanding, beginning of year | shares	2,170,780
Stock options, Granted | shares	142,499
Stock options, Exercised | shares	(920,526)
Stock options, Forfeited | shares	(333,375)
Stock options Outstanding, Outstanding, end of year | shares	1,059,378
Stock options Outstanding, Exercisable, end of year | shares	665,988
Stock options Outstanding, Weighted- average exercise price beginning of year | $ / shares	$ 6.95
Stock options, Granted, Weighted- average exercise price | $ / shares	14.77
Stock options, Exercised, Weighted- average exercise price | $ / shares	7.18
Stock options, Forfeited, Weighted- average exercise price | $ / shares	7.56
Stock options Outstanding, Weighted-average exercise price end of year | $ / shares	7.75
Stock options Exercisable, Weighted-average exercise price end of year | $ / shares	$ 7.46
Stock options, Outstanding, Weighted- average remaining contractual term (years)	6 years 6 months
Stock options, Exercisable, Weighted- average remaining contractual term (years)	5 years 2 months 12 days
Stock options, Outstanding, Aggregate intrinsic value | $	$ 1,219
Stock options, Exercisable, Aggregate intrinsic value | $	$ 653

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of non-vested stock option activity (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	554,987
Granted	142,499
Vested	(208,477)
Forfeited	(95,619)
Non-vested, end of year	393,390	554,987
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year	$ 2.54
Granted	8.10	$ 2.52	$ 1.70
Vested	2.49
Forfeited	3.26
Non-vested, end of year	$ 4.49	$ 2.54

Stock-Based Compensation - Sc_4

Stock-Based Compensation - Schedule of weighted-average assumptions to determine fair value of stock options granted (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 14.77	$ 4.64	$ 3.57
Dividend yield	0.00%	0.00%	0.00%
Expected volatility	61.70%	60.00%	48.60%
Risk-free interest rate	1.00%	0.40%	2.30%
Expected life (in years)	6 years	6 years	5 years 9 months 18 days

Stock-Based Compensation - Sc_5

Stock-Based Compensation - Schedule of stock options outstanding and exercisable (Details)	12 Months Ended
	Jan. 01, 2022$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Outstanding options | shares	1,059,378
Weighted- average remaining contractual life (years)	6 years 6 months
Weighted-average exercise price	$ 7.75
Exercisable options | shares	665,988
Weighted- average exercise price	$ 7.46
Exercise Price Range 1 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	3.25
Exercise price range High	$ 4.72
Outstanding options | shares	97,860
Weighted- average remaining contractual life (years)	6 years 6 months
Weighted-average exercise price	$ 3.58
Exercisable options | shares	87,060
Weighted- average exercise price	$ 3.44
Exercise Price Range 2 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	4.73
Exercise price range High	$ 5
Outstanding options | shares	361,385
Weighted- average remaining contractual life (years)	8 years 6 months
Weighted-average exercise price	$ 4.73
Exercisable options | shares	117,917
Weighted- average exercise price	$ 4.73
Exercise Price Range 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	5.01
Exercise price range High	$ 9.48
Outstanding options | shares	146,978
Weighted- average remaining contractual life (years)	3 years 1 month 6 days
Weighted-average exercise price	$ 6.70
Exercisable options | shares	144,978
Weighted- average exercise price	$ 6.71
Exercise Price Range 4 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	9.49
Exercise price range High	$ 9.79
Outstanding options | shares	218,470
Weighted- average remaining contractual life (years)	5 years 4 months 24 days
Weighted-average exercise price	$ 9.50
Exercisable options | shares	218,470
Weighted- average exercise price	$ 9.50
Exercise Price Range 5 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price range Low	9.80
Exercise price range High	$ 14.77
Outstanding options | shares	234,685
Weighted- average remaining contractual life (years)	6 years 7 months 6 days
Weighted-average exercise price	$ 13.17
Exercisable options | shares	97,563
Weighted- average exercise price	$ 10.93

Stock-Based Compensation - Sc_6

Stock-Based Compensation - Schedule of non-vested RSU activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares	Sep. 03, 2019	Apr. 01, 2019	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year			647,299
Granted			245,848
Vested			(285,554)
Forfeited			(101,582)
Non-vested, end of year			506,011	647,299
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year			$ 3.39
Granted	$ 1.18	$ 1.68	13.32	$ 3.20	$ 3.33
Vested			3.93
Forfeited			3.78
Non-vested, end of year			$ 7.71	$ 3.39

Stock-Based Compensation - Sc_7

Stock-Based Compensation - Schedule of non-vested PSU activity (Details) - Performance Shares [Member] - $ / shares	Sep. 03, 2019	Apr. 01, 2019	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year			3,004,675
Granted			666,332
Vested			(2,813,175)
Forfeited			(187,661)
Non-vested, end of year			670,171	3,004,675
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year			$ 3.56
Granted	$ 0.79	$ 1.77	13.90	$ 3.54	$ 3.42
Vested			3.53
Forfeited			11.40
Non-vested, end of year			$ 11.77	$ 3.56

Stock-Based Compensation (Sched

Stock-Based Compensation (Schedule of TSR PSUs using a Monte Carlo valuation model (Details) - Monte Carlo valuation model [Member]	12 Months Ended
	Jan. 01, 2022$ / shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 14.77
Dividend yield	0.00%
Expected volatility	76.90%
Risk-free interest rate	0.30%
Expected life (in years)	2 years 8 months 12 days

Stock-Based Compensation (Sch_2

Stock-Based Compensation (Schedule of non-vested TSR PSU activity (Details) - Total Shareholder Return Performance Shares "(TSR PSU") [Member]	12 Months Ended
	Jan. 01, 2022$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year | shares	0
Granted | shares	74,428
Vested | shares	0
Forfeited | shares	(3,082)
Non-vested, end of year | shares	71,346
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Non-vested, beginning of year | $ / shares	$ 0
Granted | $ / shares	23.40
Vested | $ / shares	0
Forfeited | $ / shares	23.40
Non-vested, end of year | $ / shares	$ 23.40

Stock-Based Compensation - Sc_8

Stock-Based Compensation - Schedule of valuation assumptions of RSUs and PSUs of Chief Executive Officer (Details) - $ / shares	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019	Sep. 03, 2019	Apr. 01, 2019
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 14.77	$ 4.64	$ 3.57
Dividend yield	0.00%	0.00%	0.00%
Expected volatility	61.70%	60.00%	48.60%
Risk-free interest rate	1.00%	0.40%	2.30%
Expected life (in years)	6 years	6 years	5 years 9 months 18 days
Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price				$ 2.38	$ 3.36
CEO [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 3.36
Exercise price	$ 3.36
Dividend yield	0.00%
Expected volatility	47.90%
Risk-free interest rate	2.40%
Expected life (in years)	6 years 6 months
CEO [Member] | Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 3.36
Dividend yield	0.00%
Expected volatility	55.70%
Risk-free interest rate	2.30%
Expected life (in years)	1 year 9 months 18 days

Stock-Based Compensation - Sc_9

Stock-Based Compensation - Schedule of Mr. Ennens non-vested equity awards (Details) - CEO [Member]	12 Months Ended
	Jan. 01, 2022shares
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	960,061
Vested	0
Non-vested, end of year	960,061
Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	341,746
Vested	(170,873)
Non-vested, end of year	170,873
Adjusted EBITDA performance PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	892,857
Vested	(297,619)
Non-vested, end of year	595,238
Stock price performance PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year	297,619
Vested	(297,619)
Non-vested, end of year	0

Stock-Based Compensation - S_10

Stock-Based Compensation - Schedule of valuation assumption for PSUs of Chief Financial Officer (Details) - $ / shares	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019	Sep. 03, 2019	Apr. 01, 2019
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 14.77	$ 4.64	$ 3.57
Dividend yield	0.00%	0.00%	0.00%
Expected volatility	61.70%	60.00%	48.60%
Risk-free interest rate	1.00%	0.40%	2.30%
Expected life (in years)	6 years	6 years	5 years 9 months 18 days
Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price				$ 2.38	$ 3.36
CFO [Member] | Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 2.38
Exercise price	$ 2.38
Dividend yield	0.00%
Expected volatility	49.70%
Risk-free interest rate	1.40%
Expected life (in years)	6 years 6 months
CFO [Member] | Performance Share Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Grant-date stock price	$ 2.38
Dividend yield	0.00%
Expected volatility	55.90%
Risk-free interest rate	1.40%
Expected life (in years)	2 years 1 month 6 days

Stock-Based Compensation - S_11

Stock-Based Compensation - Schedule of Mr. Huckins non-vested equity awards (Details) - CFO [Member] - shares	Sep. 03, 2019	Jan. 01, 2022
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year		262,182
Granted		0
Vested		0
Non-vested, end of year		262,182
Restricted stock units ("RSUs") [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year		218,546
Granted	327,819	29,090
Vested		(109,273)
Non-vested, end of year		138,363
Adjusted EBITDA performance PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year		173,319
Granted		0
Vested		(57,773)
Non-vested, end of year		115,546
Stock price performance PSUs [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Non-vested, beginning of year		57,773
Granted		0
Vested		(57,773)
Non-vested, end of year		0

Other Expense (Income), Net (Na

Other Expense (Income), Net (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Other Income And Expenses [Line Items]
Other asset impairments	$ 0.3
Severance benefits	0.5	$ 2.8	$ 8.4
Reversal of previously recognized stock-based compensation expense related to forfeited awards		0.9	$ 4.1
Loss on the settlement of employment-related legal matter	0.5
Loss on settlement of customer claim		2.4
Payment for cash settlement		4.4
Gain on settlement of an unrelated legal matter		2.2
South Gate, CA Facility [Member]
Other Income And Expenses [Line Items]
Exit costs	3.8
Severance benefits	1.1
Santa Maria, CA Frozen Fruit Processing Facility [Member]
Other Income And Expenses [Line Items]
Exit costs	1.4	6.3
Executive Office and Innovation Center [Member]
Other Income And Expenses [Line Items]
Exit costs	$ 0.8
Crookston, MN Facility [Member]
Other Income And Expenses [Line Items]
Other asset impairments		$ 2.7

Other Expense (Income), Net (De

Other Expense (Income), Net (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Other Income and Expenses [Abstract]
Long-lived asset impairments and facility closure costs	$ 6,298	$ 9,045	$ 308
Employee termination and recruitment costs	1,628	1,881	5,548
Divestiture costs	703	0	0
Settlement loss (gain)	163	179	(3,065)
Loss on foreign currency forward contract	0	12,658	0
Gain on sale of soy and corn business	0	0	(44,027)
Other	98	(370)	597
Total Other Expense, net	$ 8,890	$ 23,393	$ (40,639)

Income taxes (Narrative) (Detai

Income taxes (Narrative) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Tax Disclosure [Line Items]
Deferred tax assets, valuation allowance	$ 5,267	$ 4,284	$ 6,219
U.S. [Member] | Scientific research investment tax credits [Member] | Federal [Member]
Income Tax Disclosure [Line Items]
Tax credit carryforward, amount	1,600	1,500
U.S. [Member] | Research and development tax credits [Member] | State [Member]
Income Tax Disclosure [Line Items]
Tax credit carryforward, amount	900	900
U.S. [Member] | Capital loss carryforward [Member] | Federal [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	64,800	37,100
U.S. [Member] | Capital loss carryforward [Member] | State [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	3,300	8,700
Canada [Member] | Capital loss carryforward [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	27,800	27,900
Canada [Member] | Capital loss carryforward [Member] | Foreign tax authority [Member]
Income Tax Disclosure [Line Items]
Operating loss carryforwards	$ 6,000	$ 2,800

Income Taxes (Schedule of compo

Income Taxes (Schedule of components of income tax expense) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Tax Disclosure [Abstract]
Loss from continuing operations	$ (7,510)	$ (50,042)	$ (16,181)
Canadian statutory rate	26.50%	26.50%	26.50%
Income tax recovery at statutory rate	$ (1,990)	$ (13,261)	$ (4,288)
Stock-based compensation	2,166	3,169	1,975
Change in valuation allowance	975	560	(113)
Disallowed executive compensation	138	2,801	0
Foreign tax rate differential	(31)	(105)	126
Change in enacted tax rates	(442)	250	(549)
CARES Act	0	2,472	0
Other	(4,182)	1,374	(252)
Income tax benefit	$ (3,366)	$ (2,740)	$ (3,101)

Income Taxes (Schedule of com_2

Income Taxes (Schedule of components of earnings (loss) before income taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes	$ (7,510)	$ (50,042)	$ (16,181)
Canada [Member]
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes	(10,797)	(14,700)	(11,295)
U.S. [Member]
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes	3,945	(34,521)	(5,548)
Other [Member]
Income Tax Disclosure [Line Items]
Loss from continuing operations before income taxes	$ (658)	$ (821)	$ 662

Income Taxes (Schedule of com_3

Income Taxes (Schedule of components of income tax expense (benefit)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	$ (443)	$ (13,713)	$ (3,915)
Deferred income tax expense (benefit)	(2,923)	10,973	814
Income tax expense (benefit)	(3,366)	(2,740)	(3,101)
Canada [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	(9)	(154)	(1,023)
Deferred income tax expense (benefit)	299	(291)	33
U.S. [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	(75)	(14,148)	(3,424)
Deferred income tax expense (benefit)	(3,067)	10,442	731
Other [Member]
Income Tax Disclosure [Line Items]
Current income tax expense (benefit)	(359)	589	532
Deferred income tax expense (benefit)	$ (155)	$ 822	$ 50

Income Taxes (Schedule of defer

Income Taxes (Schedule of deferred tax assets and liabilities) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Income Tax Disclosure [Abstract]
Differences in property, plant and equipment and intangible assets	$ (54,761)	$ (55,105)
Capital and non-capital losses	21,540	14,388
Interest expense limitation	10,521	11,069
Tax benefit of scientific research expenditures	2,744	2,699
Inventory basis differences	1,148	1,303
Other accrued reserves	1,590	4,522
Gross deferred income tax liability	(17,218)	(21,124)
Less: valuation allowance	5,267	4,284	$ 6,219
Net deferred income tax liability	$ (22,485)	$ (25,408)

Income Taxes (Schedule of def_2

Income Taxes (Schedule of deferred tax assets and liabilities by geographic segment) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Line Items]
Net deferred income tax liability	$ (22,485)	$ (25,408)
Canada [Member]
Income Tax Disclosure [Line Items]
Net deferred income tax liability	(325)	(26)
U.S. [Member]
Income Tax Disclosure [Line Items]
Net deferred income tax liability	(22,083)	(25,150)
Other [Member]
Income Tax Disclosure [Line Items]
Net deferred income tax liability	$ (77)	$ (232)

Income Taxes (Schedule of def_3

Income Taxes (Schedule of deferred income tax valuation allowance) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Income Tax Disclosure [Abstract]
Balance, beginning of year	$ 4,284	$ 6,219
Increase (decrease) in valuation allowance	983	(1,935)
Balance, end of year	$ 5,267	$ 4,284

Earnings (Loss) Per Share (Narr

Earnings (Loss) Per Share (Narrative) (Details) - shares	1 Months Ended	12 Months Ended
	Feb. 22, 2021	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Stock options, RSUs, and certain contingently issuable PSUs [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		2,889,014	2,305,630	370,670
Stock options and RSUs [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		347,236	1,913,751	3,528,899
Series B-1 Preferred Stock [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Common shares issuable on an if-converted basis adjusted to diluted EPS		12,178,667	12,178,667
Series A Preferred Stock [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Common shares issuable on an if-converted basis adjusted to diluted EPS			12,633,427	11,333,333
Series A Preferred Stock [Member] | Oaktree Capital Management L.P. [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Exchange of Series A preferred stock, net of share issuance costs of $287 (in shares)	12,633,427
Percentage of issued and outstanding common shares on a post-exchange basis	12.30%

Earnings (Loss) Per Share (Basi

Earnings (Loss) Per Share (Basic and diluted loss per share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Numerator for basic loss per share
Loss from continuing operations	$ (4,144)	$ (47,302)	$ (13,080)
Less: dividends and accretion on Series A Preferred Stock	(4,197)	(10,328)	(8,022)
Loss from continuing operations attributable to common shareholders	(8,341)	(57,630)	(21,102)
Earnings from discontinued operations	0	124,820	12,322
Earnings (loss) attributable to common shareholders	$ (8,341)	$ 67,190	$ (8,780)
Denominator for basic loss per share
Basic weighted-average number of shares outstanding	104,098	89,234	87,787
From continuing operations	$ (0.08)	$ (0.65)	$ (0.24)
From discontinued operations	0	1.40	0.14
Basic earnings (loss) per share	$ (0.08)	$ 0.75	$ (0.10)
Numerator for diluted loss per share
Loss from continuing operations	$ (4,144)	$ (47,302)	$ (13,080)
Loss from continuing operations attributable to common shareholders	(8,341)	(57,630)	(21,102)
Earnings from discontinued operations	0	124,820	12,322
Earnings (loss) attributable to common shareholders	$ (8,341)	$ 67,190	$ (8,780)
Denominator for diluted loss per share
Basic weighted-average number of shares outstanding	104,098	89,234	87,787
Dilutive effect of the following:
Diluted weighted-average number of shares outstandin	104,098	89,234	87,787
From continuing operations	$ (0.08)	$ (0.65)	$ (0.24)
From discontinued operations	0	1.40	0.14
Diluted earnings (loss) per share	$ (0.08)	$ 0.75	$ (0.10)
Series A Preferred Stock [Member]
Numerator for basic loss per share
Less: dividends and accretion on Series A Preferred Stock	$ (1,212)	$ (8,319)	$ (8,022)
Numerator for diluted loss per share
Less: dividends and accretion on Preferred Stock	$ (1,212)	$ (8,319)	$ (8,022)
Dilutive effect of the following:
Diluted weighted-average number of shares outstandin	0	0	0
Series B-1 Preferred Stock [Member]
Numerator for basic loss per share
Less: dividends and accretion on Series A Preferred Stock	$ (2,985)	$ (2,009)	$ 0
Numerator for diluted loss per share
Less: dividends and accretion on Preferred Stock	$ (2,985)	$ (2,009)	$ 0
Dilutive effect of the following:
Diluted weighted-average number of shares outstandin	0	0	0
Stock options and restricted stock units [Member]
Dilutive effect of the following:
Diluted weighted-average number of shares outstandin	0	0	0

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Changes in Operating Assets and Liabilities, Net of Businesses Sold
Accounts receivable	$ (11,978)	$ (746)	$ 4,013
Inventories	(72,395)	6,133	7,097
Accounts payable and accrued liabilities	16,195	11,322	(5,861)
Other operating assets and liabilities	4,423	422	(4,518)
Changes in Non-Cash Working Capital, Net of Businesses Acquired or Sold, Total	(63,755)	17,131	731
Non-Cash Investing and Financing Activities
Change in additions to property, plant and equipment included in accounts payable and accrued liabilities	3,482	2,043	(2,886)
Change in accrued dividends on preferred stock	(1,769)	679	0
Dividends paid in kind on preferred stock	0	3,881	0
Change in accrued transaction costs related to the divestiture of Tradin Organic	(13,380)	13,380	0
Change in accrued debt issuance costs	(1,690)	1,690	0
Cash Paid
Interest	6,610	30,740	30,399
Income taxes	$ 3,632	$ 935	$ 410

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 02, 2021	Dec. 28, 2019	Jan. 01, 2022
Related Party Transaction [Line Items]
Related party transaction, purchases from related party	$ 15	$ 29.7
Former Managing Director [Member]
Related Party Transaction [Line Items]
Related party transaction, due from (to) related party	$ 2		$ 2

Commitments and Contingencies (

Commitments and Contingencies (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021
Loss Contingencies [Line Items]
Letters of Credit Outstanding, Amount	$ 7,300
Additional commitments under various finance leases	52,794	$ 18,813
Finance leases for expansion projects plant-based operations	$ 23,000
Eden Prairie, MN executive office and innovation center [Member]
Loss Contingencies [Line Items]
Finance lease liabilities	On August 4, 2021, the Company entered into a finance lease agreement providing for up to $14 million of financing for equipment and leasehold improvements to be installed in connection with the build-out of the Company's new executive office and innovation center located in Eden Prairie, Minnesota. The facility is being occupied under a 12-year building operating lease, with two five-year extension options. The Company recognizes costs incurred related to the build-out as construction in process in property, plant and equipment, with a finance lease liability recognized in long-term debt for the amount funded to-date under the build-out lease, which amounted to $8.7 million as at January 1, 2022. The build-out lease has an implicit rate of interest of 6.82% and a term of 48 months following completion of construction. The Company may purchase the build-out assets for a nominal amount at the end of the lease term.
Eden Prairie, MN executive office and innovation center [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Additional commitments under various finance leases	$ 14,000
Finance lease liability recognized long-term debt	$ 8,700
Midlothian, TX plant-based beverage facility [Member]
Loss Contingencies [Line Items]
Finance lease liabilities	On September 7, 2021, the Company entered into two finance lease agreements providing for up to $50 million of total financing for equipment and leasehold improvements to be installed in connection with the build-out of the Company's new plant-based beverage facility under construction in Midlothian, Texas. Once the construction of the building is completed by the landlord and is made available for use by the Company, which is expected to occur in 2022, the facility will be occupied under a 15-year operating lease, with three five-year extension options. The build-out leases do not include the manufacturing equipment for the facility (described below under "Commitments for Plant Acquisition"). The Company recognizes costs incurred related to the build-out as construction in process in property, plant and equipment, with a finance lease liability recognized in long-term debt for the amount funded to-date under the build-out leases, which amounted to $4.9 million as at January 1, 2022. The build-out leases have an implicit rate of interest of 6.45% and a term of 48 months following completion of construction. The Company may purchase the build-out assets for a nominal amount at the end of the lease term.
Midlothian, TX plant-based beverage facility [Member] | Maximum [Member]
Loss Contingencies [Line Items]
Additional commitments under various finance leases	$ 50,000
Finance lease liability recognized long-term debt	4,900
Commitments for Plant Acquisition [Member]
Loss Contingencies [Line Items]
Capital Lease Obligations	52,000
Payment of contractual commitments to purchase manufacturing equipment	14,000
Remaining contractual commitment	$ 38,000

Sunflower Purchases (Narrative)

Sunflower Purchases (Narrative) (Details) - SunOpta Grains and Foods Inc. [Member] $ in Millions	12 Months Ended
	Jan. 01, 2022USD ($)
Minnesota [Member]
Sunflower Purchases [Line Items]
Sunflower seeds purchased	$ 24.1
North Dakota [Member]
Sunflower Purchases [Line Items]
Sunflower seeds purchased	$ 17.4

Segment Information (Narrative)

Segment Information (Narrative) (Details) - Revenue Benchmark [Member] - Customer Concentration Risk [Member]	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Customer of Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Percentage of consolidated revenues from major customer	18.00%	16.00%	18.00%
Customer of Fruit-Based and Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Percentage of consolidated revenues from major customer	12.00%	14.00%	11.00%

Segment Information (Segment Re

Segment Information (Segment Revenues and Operating Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers	$ 812,624	$ 789,213	$ 721,596
Segment operating income (loss)	10,149	12,308	(24,055)
Other income (expense), net	(8,890)	(23,393)	40,639
Interest expense, net	(8,769)	(30,042)	(32,765)
Loss on retirement of debt	0	(8,915)	0
Loss from continuing operations before income taxes	(7,510)	(50,042)	(16,181)
Plant-Based Foods and Beverages [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers	470,754	415,164	361,398
Segment operating income (loss)	36,981	50,780	29,476
Fruit-Based Foods and Beverages [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers	341,870	374,049	349,852
Segment operating income (loss)	(9,320)	(7,321)	(26,873)
Global Ingredients [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment revenues from external customers	0	0	10,346
Segment operating income (loss)	0	0	(187)
Corporate Services [Member]
Segment Reporting, Revenue Reconciling Item [Line Items]
Segment operating income (loss)	$ (17,512)	$ (31,151)	$ (26,471)

Segment Information (Segment As

Segment Information (Segment Assets) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Segment Reporting Information [Line Items]
Total assets	$ 755,119	$ 585,615
Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Total assets	301,065	191,580
Fruit-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Total assets	368,976	329,151
Corporate Services [Member]
Segment Reporting Information [Line Items]
Total assets	$ 85,078	$ 64,884

Segment Information (Segment Ca

Segment Information (Segment Capital Expenditures, Depreciation and Amortization) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Segment Reporting Information [Line Items]
Capital expenditures	$ 58,297	$ 24,754	$ 28,387
Total depreciation and amortization	34,641	30,308	29,266
Plant-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Capital expenditures	38,760	11,323	15,289
Total depreciation and amortization	14,942	9,457	7,799
Fruit-Based Foods and Beverages [Member]
Segment Reporting Information [Line Items]
Capital expenditures	5,926	10,378	9,689
Total depreciation and amortization	14,918	16,304	16,702
Global Ingredients [Member]
Segment Reporting Information [Line Items]
Capital expenditures	0	0	92
Total depreciation and amortization	0	0	129
Corporate Segment [Member]
Segment Reporting Information [Line Items]
Capital expenditures	13,611	3,053	3,317
Total depreciation and amortization	$ 4,781	$ 4,547	$ 4,636

Segment Information (Revenues f

Segment Information (Revenues from External Customers) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Segment Reporting Information [Line Items]
Segment revenues from external customers	$ 812,624	$ 789,213	$ 721,596
U.S. [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers	772,333	752,000	691,838
Canada [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers	14,067	12,481	9,418
Other [Member]
Segment Reporting Information [Line Items]
Segment revenues from external customers	$ 26,224	$ 24,732	$ 20,340

Segment Information (Long-Lived

Segment Information (Long-Lived Assets) (Details) - USD ($) $ in Thousands	Jan. 01, 2022	Jan. 02, 2021
Segment Reporting Information [Line Items]
Total long-lived assets	$ 219,537	$ 158,048
U.S. [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	203,318	144,555
Mexico [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	14,124	11,511
Canada [Member]
Segment Reporting Information [Line Items]
Total long-lived assets	$ 2,095	$ 1,982